|
3DCRT |
3 Dimensional Conformal Radiotherapy |
|
|
3DXRT |
3-dimensional External Radiation Therapy |
|
|
5-FU |
5-Fluorouracil |
|
|
5-FU |
5-FluoroUracil (anti-cancer drug) |
|
|
5AR |
5 Alpha Reductase |
|
|
6-mp |
6 Mercaptopurine |
|
|
6-MP |
6-MercaptoPurine (anticancer drug) |
|
|
6-tg |
6 Thioguanine |
|
|
6-TG |
6-ThioGuanine (anticancer drug) |
|
|
a |
Aneuploid |
|
|
A |
Aortic |
|
|
A |
Allergy |
|
|
A |
Artery |
|
|
A STEN |
Aortic stenosis |
|
|
A&P |
Auscultation& percussion |
|
|
A&W |
Alive and Well |
|
|
A/G RATIO |
Albumin-globulin ratio |
|
|
A/O |
Age at Onset |
|
|
AA |
Amyloid-associated |
|
|
AA |
Anaplastic Anaemia |
|
|
AACE |
American Association for Cancer Education-Annual |
|
|
AACPI |
American Alliance of Cancer Pain Initiatives |
|
|
AACR |
Australasian Association of Cancer Registries |
|
|
AACR |
American Association for Cancer Research |
|
|
AAIR |
age-adjusted incidence rate |
|
|
AAT |
Androgen Ablation Therapy |
|
|
AB |
About |
|
|
AB |
Abort |
|
|
AB |
Asthmatic Bronchitis |
|
|
AB |
Antibody |
|
|
ABBI |
Acute Breast Biopsy Instrumentation |
|
|
ABC |
Activated B Cell |
|
|
ABC |
Advanced Breast Cancer |
|
|
ABCC |
Ashland Bellefonte Cancer Center |
|
|
ABCCC |
Alexian Brothers Cancer Care Center |
|
|
ABCD |
Asymmetry, Border, Color, and Diameter |
|
|
ABCD |
After Breast Cancer Diagnosis, Inc. |
|
|
ABCG |
Associação Brasileira de Câncer Gástrico |
|
|
ABCL |
Acute Basal Cell Lethality |
|
|
ABD |
Abdomen |
|
|
ABDCTSCAN |
abdominal CAT scan |
|
|
ABMT |
Autologous Bone Marrow Transplant |
|
|
ABMT |
allogenic bone marrow transplantation |
|
|
ABN |
Abnormal |
|
|
ABP |
Arterial Blood Pressure |
|
|
ABPI |
Association of the British Pharmaceutical Industry |
|
|
Abst |
Abstract |
|
|
ABTA |
American Brain Tumor Association |
|
|
AC |
After Chemo |
|
|
AC |
Anterior Chamber |
|
|
ACB |
Alberta Cancer Board |
|
|
ACCC |
Association of Community Cancer Centers |
|
|
ACCN |
Appalachia Community Cancer Network |
|
|
acco |
American Childhood Cancer Organization |
|
|
ACCP |
Alliance for Cervical Cancer Prevention |
|
|
ACDC |
Advanced Center For Detection Of Cancer |
|
|
ACDM |
Association for Clinical Data Management |
|
|
ACH |
Adrenal Cortical Hormone |
|
|
Acid Phos |
Acid Phosphatase |
|
|
ACLT |
African Caribbean Leukaemia Trust |
|
|
ACO |
Action Cancer Ontario (French title of Cancer Care Ontario) |
|
|
ACOG |
American College of Obstetricians and Gynecologists |
|
|
ACOR |
Association of Cancer Online Resources |
|
|
ACORN |
Accelerated Community Oncology Research Network |
|
|
ACR |
Allowed Cell Rate |
|
|
ACRP |
Australian Cancer Research Program |
|
|
ACRPI |
Association of Clinical Research for the Pharmaceutical Industry |
|
|
ACS |
American Cancer Society |
|
|
ACSR |
AIDS and Cancer Specimen Resource |
|
|
ACTH |
adrenocorticotrophic hormone |
|
|
ADCC |
Alliance of Dedicated Cancer Centers |
|
|
ADCC |
Antibody-Dependant Cellular Cytoxicity |
|
|
ADENOCA |
Adenocarcinoma |
|
|
ADH |
Antidiuretic Hormone |
|
|
ADJ |
Adjacent |
|
|
ADM |
Admit |
|
|
ADR |
Adverse Drug Reaction |
|
|
ADT |
Androgen Deprivation Therapy |
|
|
AE |
Adverse Event |
|
|
AF |
Atrial Fibrillation |
|
|
AFBMTC |
Armed Forces Bone Marrow Transplant Centre |
|
|
AFF |
afferent |
|
|
AFP |
amniotic fluid alphafetoprotein |
|
|
AFP |
and fetal alphafetoprotein |
|
|
AFP |
analysed for alphafetoprotein |
|
|
AFP |
Alpha Fetoprotein |
|
|
AFP |
assayfor alphafetoprotein |
|
|
AFRE |
Asbestos Fiber Release Episode |
|
|
AFUD |
American Federation for Urologic Disease |
|
|
Ag |
Silver (Argentum) |
|
|
Ag |
Antigen |
|
|
AGC |
atypical glandular cells |
|
|
AGL |
Acute Granulocytic Leukemia |
|
|
AGNO3 |
Silver nitrate |
|
|
AIDS |
Acquired Immune Deficiency Sydrome |
|
|
AIDS |
Acquired Immune Deficiency Syndrome (see also SIDS and HIV) |
|
|
AIF |
Apoptosis Inhibitor Factor |
|
|
AIOM |
Italian Association for Medical Oncology |
|
|
AIRO |
Associazione Italiana di Radioterapia Oncologica |
|
|
AITR |
Activation- Inducible TNFR family member |
|
|
ajcc |
American Joint Committee on Cancer's |
|
|
AK(A) |
Above knee (amputation) |
|
|
AL |
Acute Leukemia |
|
|
ALAT |
Alanine Aminotransferase |
|
|
Alb |
Albumin |
|
|
ALCL |
Anaplastic Large Cell Lymphoma |
|
|
ALI |
Annual Limit on Intake |
|
|
ALK |
Anaplastic Lymphoma Kinase |
|
|
ALK PHOS |
Alkaline Phosphatase |
|
|
ALL |
Aberration in Acute Lymphoblastic Leukemia |
|
|
ALL |
Adult Lymphoblastic Leukemia |
|
|
ALL |
Acute Lymphocytic Leukemia |
|
|
ALND |
Axillary Lymph Node Dissection |
|
|
ALPS |
Autoimmune Lymphoproliferative Syndrome |
|
|
ALS |
Advanced Life Support |
|
|
ALT |
Alanine Aminotransferase |
|
|
AMA |
Against Medical Advice |
|
|
Amb |
Ambulatory |
|
|
AMKL |
Acute Megakaryocytic Leukemia |
|
|
AML |
Acute Myeloid leukaemia |
|
|
AML |
Acute Myelogenous Leukemia |
|
|
AMP |
Amputation |
|
|
ANA |
Antinuclear Antibody |
|
|
ANAP |
Anaplastic |
|
|
ANAT |
Anatomy |
|
|
ANC |
Absolute Neutrophil Count |
|
|
ANCA |
Anti-Neutrophil Cytoplasmic Antibodies |
|
|
ANCO |
Association of Northern California Oncologists |
|
|
ANCR |
Association of the Nordic Cancer Registries |
|
|
ANCT |
Adjacent Non-Cancerous Tissue |
|
|
ANED |
Alive, No Evidence of Disease |
|
|
ANES(TH) |
Anesthesia |
|
|
ANEUP |
Aneuploid |
|
|
ANLL |
Acute Non-Lymphocytic Leukemia |
|
|
ANLL |
Acute Non-Lymphatic Leukaemia |
|
|
ANT |
Anterior |
|
|
ante |
before |
|
|
AOCN |
Advanced Oncology Certified Nurse |
|
|
AP |
Auscultation and Percussion |
|
|
AP |
anterior pituitary |
|
|
AP&LAT |
anteroposterior and lateral |
|
|
APBC |
Advanced Pancreatic Biliary Adenocarcinoma |
|
|
APCR |
Australian Prostate Cancer Research |
|
|
APF |
Asset Protection Forum |
|
|
APL |
Acute Promyelocytic Leukemia |
|
|
APML |
Acute Promyelocytic Leukemia |
|
|
APOS |
American Psychosocial Oncology Society |
|
|
APOT |
Amplification of Papillomavirus Oncogene Transcripts |
|
|
APP |
Appendix |
|
|
ARC |
AIDS Related Complex |
|
|
ARCP |
Algoma Regional Cancer Program |
|
|
ARD(S) |
Acute respiratory disease |
|
|
ARMS |
Alveolar Rhabdomyosarcoma |
|
|
AROI |
Association of Radiation Oncology of India |
|
|
ART |
Analyze, Revitalize, and Target |
|
|
ART |
Adaptive Radiation Therapy |
|
|
ART |
Artery |
|
|
ARV |
Associate Remote Viewing |
|
|
AS |
Aortic Stenosis |
|
|
AS |
Angiosarcoma |
|
|
as |
adenosquamous carcinoma |
|
|
AS |
Arteriosclerosis |
|
|
ASCEND |
Anne Scandalios Cancer Ends Now Directive |
|
|
asco |
American Society of Clinical Oncology's |
|
|
ASCR |
Alabama Statewide Cancer Registry |
|
|
ASCVD |
Arteriosclerotic Cardiovascular Disease |
|
|
ASH |
American Society for Hematology |
|
|
ASHD |
Arteriosclerotic Heart Disease |
|
|
ASP |
aspiration pneumonia |
|
|
ASR |
aldosterone secretion rate |
|
|
ASR |
Age Standardised Rate |
|
|
ASS |
Anterior Superior Spine |
|
|
ASSO |
Austrian Society for Surgical Oncology |
|
|
AST |
Aspartate Aminotransferase |
|
|
astro |
l'American Society for Therapeutic Radiology and Oncology |
|
|
AT |
aneuploid/tetraploid |
|
|
AT/RT |
Atypical Teratoid Rhabdoid Tumor |
|
|
ATC |
Anaplastic Thyroid Cancer |
|
|
ATC |
Anatomical Therapeutic Chemical |
|
|
ATL |
Adult T-cell Leukemia |
|
|
ATLL |
Adult T-Cell Leukemia-Lymphoma |
|
|
ATLS |
Acute Tumor Lysis Syndrome |
|
|
ATP |
Adenosine Triphosphate (reg: 56-65-5) |
|
|
ATR |
Achilles Tendon Reflex |
|
|
Au |
Gold (Latin ''Aurum'') |
|
|
AUA |
American Urological Association |
|
|
AUC |
Area under the Curve (statistics) |
|
|
AUT |
Autopsy |
|
|
AV |
Arteriovenous |
|
|
AV |
Aortic Valve |
|
|
AWBC |
Avon Walk for Breast Cancer |
|
|
AX |
Axis |
|
|
ax |
axilla |
|
|
B |
Born |
|
|
B-ALL |
B-cell acute lymphoblastic leukaemia |
|
|
B-CELLS |
Special lymphocytes formed in bone marrow |
|
|
B/D |
Well developed |
|
|
B/f |
Black Female |
|
|
B/M |
Black male |
|
|
B/P |
blood pressure |
|
|
BA |
Barium |
|
|
babc |
Bikers Against Breast Cancer |
|
|
babc |
Brides Against Breast Cancer |
|
|
BACR |
British Association for Cancer Research |
|
|
BAER |
Brainstem Auditory Evoked Response |
|
|
BAL |
Biphenotypic Acute Leukemia |
|
|
BAS |
Basal |
|
|
BASO |
British Association of Surgical Oncologists |
|
|
BASOS |
Basophil |
|
|
BBB |
Blood Brain Barrier |
|
|
BBC |
Bilateral Breast Cancer |
|
|
BBDR |
Benign Breast Disease Registry |
|
|
BBT |
Basal Body Temperature |
|
|
BC |
breast carcinoma |
|
|
BC |
bone conduction |
|
|
BC |
Birth Control |
|
|
BC |
Buccocervical |
|
|
BC |
Breast Cancer |
|
|
BC |
Brain Cancer |
|
|
BCA |
Breast Cancer Auctions |
|
|
BCA |
Breast Carcinoma |
|
|
BCA |
Breast Cancer Action |
|
|
BCAC |
Basal Cell Adenocarcinoma |
|
|
BCAP |
Bowel Cancer Awareness Project |
|
|
BCC |
Basal Cell Carcinoma |
|
|
BCC |
Breast Cancer Center |
|
|
BCCA |
British Columbia Cancer Agency |
|
|
BCCLs |
Breast Cancer Cell Lines |
|
|
BCCP |
Breast & Cervical Cancer Program |
|
|
BCCS |
Breast and Cervical Cancer Services |
|
|
BCCs |
Basal Cell Carcinomas |
|
|
BCCT |
Breast Cervical Cancer Treatment |
|
|
BCCT |
Breast Cancer Center Team |
|
|
BCE |
Basal Cell Epithelioma |
|
|
BCFs |
Breast Cancer Families |
|
|
BCG |
bacillus of Calmette and Guérin |
|
|
BCHC |
Bristol Cancer Help Centre |
|
|
BCHCP |
Backus Community Hospital Cancer Program |
|
|
BCIS |
Breast Carcinoma In-Situ |
|
|
BCL |
B Cell Leukemia |
|
|
BCL |
B cell lymphomas |
|
|
BCLC |
Barcelona Clinic Liver Cancer |
|
|
BCLL |
B Cell Lymphocytic Leukemia |
|
|
BCNA |
Breast Cancer Network Australia |
|
|
BCO |
Breast Cancer Online |
|
|
BCOP |
Board Certified Oncology Pharmacist |
|
|
BCP-ALL |
B-cell precursor acute lymphoblastic leukemia |
|
|
BCPs |
Breast Cancer Patients |
|
|
BCPT |
Breast Cancer Prevention Trial |
|
|
BCQS |
Breast cancer quality standard |
|
|
BCRC |
Breast Cancer Resource Center |
|
|
BCRC |
Breast Cancer Resource Committee |
|
|
BCRP |
Breast Cancer Resistance Protein |
|
|
BCRT |
Breast Cancer Research Trust |
|
|
BCRT |
Bone Cancer Research Trust |
|
|
BCSC |
Breast Cancer Surveillance Consortium |
|
|
BCT |
Breast Conservation Terapy |
|
|
BCTP |
Breast Cancer Training Program |
|
|
BD |
Bile Duct |
|
|
BDA |
Bile Duct Adenoma |
|
|
BDC |
Bellini Duct Carcinoma |
|
|
BDCs |
Biliary Duct Carcinomas |
|
|
BE |
Barium Enema |
|
|
BEB |
Benign Essential Blepharospasm |
|
|
BEST |
Breast Examination Self Teaching |
|
|
BFPC |
Bruins Fighting Pediatric Cancer |
|
|
BGD |
Benign Gynecological Disease |
|
|
BHC |
Benign Hereditary Chorea |
|
|
BID |
Benign Inflammatory Disorders |
|
|
BID |
Bis In Die (Twice a day) |
|
|
BIFC |
Benign Infantile Familial Convulsions |
|
|
BIG |
Breast International Group |
|
|
BIL |
Bilateral |
|
|
BILI |
Bilirubin |
|
|
BIRADS |
Breast Imaging Reporting And Data System |
|
|
BJC |
British Journal of Cancer |
|
|
BK(A) |
Below knee(amputation) |
|
|
BL |
Burkitt lymphoma |
|
|
BLL |
Burkitt Like Lymphoma |
|
|
BLND |
Bilateral Lymph Node Dissection |
|
|
BLV |
Bovine Leukemia Virus |
|
|
BLV |
Bovine Leukosis Virus |
|
|
BM |
Blood Monitoring |
|
|
BM |
Bone Marrow |
|
|
BM |
Bowel Movement |
|
|
BMA |
British Medical Association |
|
|
BMB |
Bone Marrow Biopsy |
|
|
BMBs |
Bone Marrow Biopsies |
|
|
BME |
Benign Myoclonic Epilepsies |
|
|
BMJ |
British Medical Journal |
|
|
BML |
Benign Metastasizing Leiomyoma |
|
|
BMPA |
Benign Metastasizing Pleomorphic Adenoma |
|
|
BMR |
Basal Metabolism Rate |
|
|
BMR |
Basal Metabolic Rate |
|
|
BMT |
Bone Marrow Transplantation |
|
|
BN |
Blue Nevi |
|
|
BN |
Benign Nevi |
|
|
BNF |
British National Formulary |
|
|
BNLI |
British National Lymphoma Investigation |
|
|
BNML |
Brown Norway Myelocytic Leukemia |
|
|
BOA |
British Oncology Association |
|
|
BODMA |
British Oncology Data Managers Association |
|
|
BOPA |
British Oncology Pharmacy Association |
|
|
BOSS |
Breast and Ovarian Surveillance Service |
|
|
BOT |
Borderline Ovarian Tumors |
|
|
BOTs |
Borderline Ovarian Tumors |
|
|
BP |
Bluestein prediction |
|
|
BP |
Blood Pressure |
|
|
BPA |
Bullous Pemphigoid Antigen |
|
|
BPAC |
Blood Products Advisory Committee |
|
|
BPBD |
Benign Proliferative Breast Disease |
|
|
BPD |
Benign Prostatic Disease |
|
|
BPD |
Biliopancreatic Diversion |
|
|
BPE |
Benign Prostate Enlargement |
|
|
BPH |
Benign Prostate Hyperplasia |
|
|
BPH |
Benign Prostate Hypertrophy |
|
|
BPNSTs |
Benign Peripheral Nerve Sheath Tumors |
|
|
BPSA |
baseline PSA |
|
|
BPV |
Bovine Papiloma Virus |
|
|
BRACHY |
Brachytherapy |
|
|
BRBN |
Blue Rubber Bleb Nevus |
|
|
BRIC |
Benign Recurrent Intrahepatic Cholestasis |
|
|
BRM |
Biological Response Modifier |
|
|
BRV |
Benign Recurrent Vertigo |
|
|
BS |
Bone Scan |
|
|
BSA |
Body Surface Area |
|
|
BSC |
Basaloid Squamous Carcinoma |
|
|
BSC |
Best Supportive Care |
|
|
BSC |
Bone scan |
|
|
BSE |
Breast Self-Examination |
|
|
BSO |
Bilateral Salpingo-Oophorectomy |
|
|
BSOC |
Basic Sciences in Oncology Course |
|
|
BT |
Brain Tumor |
|
|
BTCD |
The Brain Tumor Center at Duke |
|
|
BTW |
Breast Test Wales (Welsh breast cancer screening program) |
|
|
BUN |
Blood Urea Nitrogen |
|
|
BUS |
Bartholin's, uethral & Skene's glands |
|
|
BX |
Biopsy |
|
|
C |
Cancer |
|
|
C |
Cell |
|
|
C |
Centigrade |
|
|
c |
Cellulose |
|
|
C-SPINE |
Spine, Cervical |
|
|
C/O |
Complains Of |
|
|
C/W |
Consistent With |
|
|
C/W |
Continue With |
|
|
C1 - C7 |
Cervical vertebrae (spine eg. C7 = seventh cervical vertebra) |
|
|
CA |
Cancer Antigen |
|
|
CA |
Carcinoma |
|
|
CA |
Cancer |
|
|
CA |
Colorectal Adenoma |
|
|
CA |
Calcium |
|
|
CA |
Cavernous Angiomas |
|
|
CA-125 |
Cancer Antigen 125 |
|
|
CAA |
Cancer Arthritis Artery |
|
|
CAB |
Complete Androgen Blockade |
|
|
CAIB |
Cancer Alternative Information Bureau |
|
|
CAIS |
Cancer Agency Information System |
|
|
CALGB |
Cancer and Leukemia Group B |
|
|
CALL |
Common Acute Lymphoblastic Leukemia |
|
|
CALL |
common acute lymphocytic leukemia |
|
|
CALL |
Congenital Acute Lymphoblastic Leukemia |
|
|
CALLA |
Common Acute Lymphocytic Leukemia Associated |
|
|
CALLA |
common acute lymphoblastic leukemia antigen |
|
|
CALLA |
Common Acute Lymphocytic Leukemia Antigen |
|
|
CALLA |
Common Acute Lymphoblastic Leukemia Antiserum |
|
|
CALM |
Clathrin Assembly Lymphoid Myeloid leukemia protein |
|
|
CALM |
Cancer and Leukaemia Movement |
|
|
CAMC |
Cancer Association of Mercer County |
|
|
CAN |
Cancer Action Network |
|
|
CANCERS |
Cancerous |
|
|
cANLL |
Congenital Acute Nonlymphoblastic Leukemia |
|
|
CAP |
Cancer of the prostate |
|
|
CAPO |
Canadian Association of Psychosocial Oncology |
|
|
CARE |
Cancer Awareness Resource Environment |
|
|
caro |
Canadian Association of Radiation Oncology |
|
|
CASUAL |
Cancer Awareness Saves Unlimited Adult Lives |
|
|
CATO |
Computer Aided Therapy for Oncology |
|
|
CAUSE |
Cancer Awareness And Understanding Self Examination |
|
|
CB |
Cancer Board |
|
|
CBC |
Complete Blood Count |
|
|
CBCC |
Colorado Breast Cancer Coalition |
|
|
CBCG |
Cochrane Breast Cancer Group |
|
|
CBCL |
Cutaneous B-Cell Lymphoma |
|
|
CBCS |
Carolina Breast Cancer Study |
|
|
CBD |
Common Bile Duct |
|
|
CBN |
Cellular Blue Nevi |
|
|
CBT |
Cord Blood Transplant |
|
|
CBT |
Childhood brain tumors |
|
|
CBT |
Carotid Body Tumor |
|
|
CC |
Cubic Centimeter |
|
|
CC |
Cervical Cancer |
|
|
CC |
Chief Complaint |
|
|
CC |
Cancer Center |
|
|
CC |
cervical carcinoma |
|
|
CC |
colorectal cancer |
|
|
CC |
Colorectal Carcinoma |
|
|
CC |
Colon Cancer |
|
|
CCA |
Children's Cancer Association |
|
|
CCAF |
Cancer Center Administrators Forum |
|
|
CCAI |
Comprehensive Cancer Alliance for Idaho |
|
|
CCAP |
Cancer Chromosome Aberration Project |
|
|
CCC |
Cholangiocellular Carcinoma |
|
|
cccr |
Competence Centre for Cancer Research |
|
|
CCCR |
Center for Childhood Cancer Research |
|
|
CCCR |
Center for Colon Cancer Research |
|
|
ccdt |
Current Cancer Drug Targets |
|
|
CCE |
Clear Cell Ependymoma |
|
|
CCF |
Congestive Cardiac Failure |
|
|
CCF |
Cleveland Clinic Foundation |
|
|
CCG |
Children's Cancer Group |
|
|
CCH |
C Cell Hyperplasia |
|
|
CCIC |
Clinical Cancer Investigations Committee |
|
|
CCIF |
Cancer Center Isolation Facility |
|
|
CCIR |
Center for Cancer Immunology Research |
|
|
CCK |
Cancer Center Karolinska |
|
|
CCLE |
Cancer Cell Line Encyclopedia |
|
|
CCNC |
Cancer Centers of North Carolina |
|
|
CCO |
Cancer Care Ontario |
|
|
CCOP |
Community Clinical Oncology Program |
|
|
CCORE |
Collaboration of Cancer Outcomes Research and Evaluation |
|
|
CCPR |
Cancer Cell Production Rate |
|
|
CCPRO |
Center for Cancer Prevention Research Outreach |
|
|
CCR |
California Cancer Registry |
|
|
CCR |
Center for Cancer Research |
|
|
CCR |
Continuous Complete Remission |
|
|
CCRC |
Cancer Circuitry Research Consortium |
|
|
CCRC |
Cancer Care Research Centre |
|
|
CCRC |
Chromophobe Cell Renal Carcinoma |
|
|
CCRC |
Community Cancer Resource Center |
|
|
CCRC |
Clear Cell Renal Carcinoma |
|
|
CCRCC |
Clear Cell Renal Cell Carcinoma |
|
|
CCRF |
Children's Cancer Research Fund |
|
|
CCRG |
Children's Cancer Research Group |
|
|
CCRG |
Children's Cancer Research Group (Oxford, UK) |
|
|
CCRI |
Cancer Research Institute |
|
|
CCRI |
Childhood Cancer Research Institute |
|
|
CCRI |
Childrens Cancer Research Institute |
|
|
ccrn |
Childhood Cancer Research Network |
|
|
CCRP |
Colorado Cancer Research Program |
|
|
ccs |
clear cell sarcoma |
|
|
CCS |
Cancer Control Society |
|
|
CCS |
Canadian Cancer Society |
|
|
CCSB |
Center of Cancer Systems Biology |
|
|
CCSB |
Cancer Center of Santa Barbara's |
|
|
CCSP |
Comprehensive Cancer Support Program |
|
|
CCSV |
Chinese Cancer Society of Victoria, Inc. |
|
|
cctr |
Current Cancer Therapy Reviews |
|
|
CCU |
Coronary Care Unit |
|
|
CD |
Cowden Disease |
|
|
CDC |
Collecting duct carcinoma |
|
|
CDER |
Center for Drug Evaluation and Research (Food & Drug Administration) |
|
|
cdoc |
California Dialogue on Cancer |
|
|
CDP |
Cancer Diagnosis Program |
|
|
CE |
Coelomic Epithelium |
|
|
CEA |
CarcinoEmbryonic Agent |
|
|
CEA |
Carcinoembryonic Antigen |
|
|
CEA |
Carcinogenic Embryonic Antigen |
|
|
CECOG |
Central European Cooperative Oncology Group |
|
|
CEL |
Chronic Eosinophilic Leukemia |
|
|
CEMA |
Chronic Enteroviral Meningoencephalitis in Agammaglobulinemia |
|
|
CEST |
Childhood Endodermal Sinus Tumors |
|
|
cet |
Cancer Exercise Trainer |
|
|
CET |
Central European Tucnak |
|
|
CF |
Chondromyxoid Fibroma |
|
|
CFCE |
Center for Functional Cancer Epigenetics |
|
|
CFS |
Cancer Family Syndrome |
|
|
CFS |
congenital fibrosis syndromes |
|
|
CG |
Control Group |
|
|
CGAP |
Cancer Genome Anatomy Project |
|
|
CGCT |
Cultured Cerebral Germ Cell Tumor |
|
|
CGFL |
Centre Georges-François Leclerc |
|
|
CGH |
Comparative Genomic Hybridisation |
|
|
CGH |
Comparative Genomic Hybridization - cytogenetics method |
|
|
CGL |
Chronic Granulocytic Leukemia |
|
|
CGL |
Congenital Generalized Lipodystrophy |
|
|
cgt |
Cancer Gene Therapy |
|
|
CGY |
CentiGray (unit of radiation) |
|
|
CGY |
Centigray |
|
|
CHB |
Combined Hormone Blockade |
|
|
CHB2 |
CHB with 2 medications |
|
|
CHB3 |
CHB with 3 medications |
|
|
CHBNDT |
CHB non-detectable time |
|
|
CHC |
Carcinome Hépatocellulaire |
|
|
Chemo |
ChemoTherapy |
|
|
CHF |
Congestive Heart Failure |
|
|
CHL |
Classic Hodgkin Lymphoma |
|
|
CHOA |
Childhood Hematology Oncology Associates |
|
|
CHOP |
cyclophosphamide, Halotestin, Oncovin, prednisone |
|
|
CHOP |
Cyclophosphamide, Doxorubicin, Oncovin, Prednisone |
|
|
CHR |
Chronic |
|
|
CHT |
combined hormonal treatment |
|
|
CHT |
Combined Hormonal Therapy |
|
|
CHUMS |
Children's Hope For Understanding Multiple Sclerosis |
|
|
CIA |
Chemotherapy Induced Alopecia |
|
|
CIC |
Cancer Immunotherapy Consortium |
|
|
CIG |
Cigarettes |
|
|
CIIC |
Cancer Immunology and Immunotherapy Center |
|
|
CIMP |
CpG Island Methylated Phenotype |
|
|
CIN |
Conjunctival Intraepithelial Neoplasia |
|
|
CIN |
Cervical Intraepithelial Neoplasia |
|
|
CIN |
Chemotherapy Induced Neutropenia |
|
|
CINV |
chemotherapy-induced nausea and vomiting |
|
|
cIP |
Cancer Imaging Program |
|
|
CIPA |
Carcinomas In Pleomorphic Adenoma |
|
|
CIS |
Carcinoma in Situ |
|
|
CISS |
Cancer Information and Support Services |
|
|
CKN |
Cancer Knowledge Network |
|
|
CL |
Congenital Leukaemia |
|
|
Cl |
Caseous Lymphadenitis |
|
|
CL |
Clinical Leaflet |
|
|
CLAN |
Cancer Link Aberdeen and North |
|
|
CLCC |
Centres de Lutte Contre le Cancer |
|
|
CLI |
Central Lymphatic Irradiation |
|
|
CLIC |
Cancer and Leukaemia in Children |
|
|
CLIC |
Cancer and Leukemia in Childhood |
|
|
CLL |
Chronic Lymphoid Leukaemia |
|
|
CLP |
Common Lymphoid Progenitor |
|
|
cm |
Centimeter |
|
|
CM |
Canova Method |
|
|
CM |
Customized Microscopy |
|
|
CM |
cutaneous melanoma |
|
|
CM |
Clinically Malignant |
|
|
CMD |
Chronic Myeloid Disorders |
|
|
CMGM |
chronic megakaryocytic granulocytic metaplasia |
|
|
CMGM |
Chronic Megakaryocytic Granulocytic Myelosis |
|
|
CMI |
T-cell mediated immunity |
|
|
CML |
Chronic Myelogenic Leukemia |
|
|
CML |
chronic myeloid |
|
|
CML |
Chronic Myeloid Leukemia |
|
|
CML |
Chronic Myeloctyic Leukemia |
|
|
CML |
cutaneous malignant lymphomas |
|
|
CMML |
Chronic Myelomonocytic Leukemia |
|
|
CMRO |
Central Maryland Radiation Oncology |
|
|
CMTN |
Cáncer de mama triple negativo |
|
|
CMV |
Contract Monitoring Visit |
|
|
CMV |
CytoMegalo Virus |
|
|
CMV |
Cytomegalovirus |
|
|
CNA |
California Nurses Association |
|
|
CNS |
Central Nervous System |
|
|
CNSL |
Central Nervous System Lymphoma |
|
|
cnz |
Cancer Network Zurich |
|
|
CO2 |
Carbon Dioxide |
|
|
Co60 |
Cobalt 60 |
|
|
CoA |
Community Oncology Alliance |
|
|
COAST |
Cancer Outreach and Support Together |
|
|
COC |
Commission on Cancer |
|
|
coca |
Children's Oncology Camping Association |
|
|
COCA |
Colorado Ovarian Cancer Alliance |
|
|
COIN |
Clinical Oncology Information Network |
|
|
COMS |
Collaborative Ocular Melanoma Study |
|
|
CONFIRM |
Colonoscopy versus Fecal Immunochemical Test In Reducing Mortality |
|
|
Cor |
heart |
|
|
CORE |
Cancer Outreach And Relief Effort |
|
|
COS |
Canadian Oncology Society |
|
|
COSD |
Cancer Outcomes and Services Dataset |
|
|
COTC |
Cancer Outpatient Treatment Clinic |
|
|
COTC |
Comparative Oncology Trials Consortium |
|
|
CP |
capsular penetration |
|
|
CPC |
Choroid Plexus Carcinoma |
|
|
CPCC |
Chicago Prostate Cancer Center |
|
|
CPCSS |
Carolina Prostate Cancer Screening Study |
|
|
CPCT |
Center For Personalized Cancer Treatment |
|
|
cpct |
Center for Personalized Cancer Therapy |
|
|
CPFP |
Cancer Prevention Fellowship Program |
|
|
cpm |
Cis-platin, Cyclophosphamide |
|
|
CPM |
CycloPhosphaMide (anticancer drug) |
|
|
CPON |
Certified Pediatric Oncology Nurse |
|
|
CPR |
Cardio-Pulmonary Resuscitation |
|
|
CPR |
Cancer Progress Report |
|
|
CPRC |
Cancer Prevention Research Center |
|
|
CPRC |
Cancer Protocol Review Commitee |
|
|
cprf |
Cancer and Polio Research Fund |
|
|
Cps |
Cancer Prevention Survey |
|
|
cPSA |
Complexed Prostate Specific Antigen |
|
|
CPTC |
Clinical Proteomic Technologies for Cancer |
|
|
CR |
Complete Remission |
|
|
CR |
Complete Response |
|
|
CRA |
Clinical Research Associate |
|
|
CRAB |
Cancer Research and Biostatistics |
|
|
CRAD |
Cancer Registrars Association of the Dakotas |
|
|
CRAT |
Centre de Référence sur les Agents Tératogènes |
|
|
CRC |
Colorectal Carcinoma |
|
|
CRC |
Cancer Research Campaign |
|
|
CRCA |
Colorectal Cancer |
|
|
CRCC |
Cell Renal Cell Carcinoma |
|
|
Creat |
Creatinine |
|
|
CRF |
Case Report Form |
|
|
CRF |
Chronic Renal Failure |
|
|
CRIS |
Cancer Research Information System |
|
|
CRO |
Contract Research Organization |
|
|
CRO |
Contract Research Organisation |
|
|
CRPC |
Castration-Resistant Prostate Cancer |
|
|
cryo |
cryosurgery |
|
|
cryo |
cryotherapy |
|
|
cryo |
cryoablation |
|
|
CS |
clinical stage |
|
|
cs |
Cancer Survivors |
|
|
CS |
Cesium |
|
|
csc |
Cancer Support Community |
|
|
CSC |
Cancer Stem Cell |
|
|
CSCT |
Cell Specific Cancer Therapy |
|
|
CSE |
Common Sense Exam |
|
|
CSF |
Cerebrospinal Fluid |
|
|
CSF |
Colony-stimulating factor |
|
|
CSF |
colony stimulating factor |
|
|
CSM |
Committee on Safety of Medicines |
|
|
CSM |
Unnited Kingdom Committee on Safety of Medicines |
|
|
CSN |
Cancer Survivors Network |
|
|
CSP |
Cervical Screening Program |
|
|
CSP |
Cystosarcoma phyllodes |
|
|
CSP |
Cancer Surveillance Program |
|
|
CSR |
Corrected Survival Rate |
|
|
CSUF |
Cancer Service Users Forum |
|
|
CSUG |
Cancer Services User Group |
|
|
CT |
Computed Tomography |
|
|
CT |
Chemotherapy |
|
|
CT |
Computerised axial tumography |
|
|
CT SC |
Computerized tomography scan |
|
|
CTC |
Circulating Tumor Cells |
|
|
CTC |
Common Toxicity Criteria |
|
|
CTCA |
Cancer Treatment Center of America |
|
|
CTCI |
Cell Therapy Cancer Immunotherapy |
|
|
CTCL |
Cutaneous T Cell Lymphoma |
|
|
CTID |
Cancer Treatment Induced Diarrhea |
|
|
CTLA-4 |
Cytotoxic T-lymphocyte–associated antigen |
|
|
CTO |
Clinical Trials Office |
|
|
CTOS |
Connective Tissue Oncology Society |
|
|
CTR |
California Tumor Registry |
|
|
CTR |
Certified Tumor Registrar |
|
|
CTR |
Cancer Therapy and Research |
|
|
CTRC |
Cancer Therapy and Research Center |
|
|
CTRG |
Cancer Therapeutics Research Group |
|
|
CTRT |
Chemotherapy-Thoracic RadioTherapy |
|
|
ctrt |
Cancer Treatment and Research Trust |
|
|
CTSU |
Cancer Trials Support Unit |
|
|
CTX |
Clinical Trials Exemption |
|
|
CUP |
Cancer of Unknown Primary |
|
|
CURE |
Continuing Umbrella of Research Experience |
|
|
CVA |
Cerebrovascular Accident |
|
|
CVA |
Cerebro-Vascular Accident (stroke) |
|
|
CVA |
Constovertebral angle |
|
|
CVC |
Central Venous Catheter |
|
|
CVP |
Central Venous Pressure |
|
|
CX |
Cervix |
|
|
CX |
Cos X |
|
|
CxCa |
Cervical Cancer |
|
|
CXR |
chest xray |
|
|
CXR |
Chest X-Ray |
|
|
cysto |
Cystoscopy |
|
|
CYTO |
Cytology |
|
|
d |
Diploid |
|
|
D&C |
Dilatation and Curettage |
|
|
D/C |
Discharge |
|
|
D/H |
Drug History |
|
|
D/W |
Discussed With |
|
|
DAT |
Direct Antiglobulin Tests |
|
|
DBOP |
Division of Biologic Oncology Products |
|
|
dc |
discontinue |
|
|
DC |
Discharge |
|
|
DCIS |
Ductal Carcinoma In Situ |
|
|
DCP |
Division of Cancer Prevention |
|
|
DCRA |
Delaware Cancer Registrars Association |
|
|
DCT |
Deep Cryogenic Treatment |
|
|
DCTB |
Dansk Center for Translationel Brystkræftforskning |
|
|
DD |
Discharge Diagnosis |
|
|
DDAVP |
Desmopressin test for urine osmolality |
|
|
DDX |
Differential Diagnosis |
|
|
Dept |
Department |
|
|
Derm |
Dermatology |
|
|
DET |
Detached Garage |
|
|
DET |
Detached Duty |
|
|
DFCI |
Dana-Farber Cancer Institute |
|
|
DFCI |
Data- Farber Cancer Institute |
|
|
DFI |
Disease-Free Interval |
|
|
DFS |
disease free survival time |
|
|
DHL |
Diffuse Histiocytic Lymphoma |
|
|
DI |
Diabetes Insipidus |
|
|
DIAM |
Diameter |
|
|
DILL |
Diffuse intermediate lymphocytic lymphoma |
|
|
Dis |
Disease |
|
|
DISCH |
Discharge |
|
|
DL |
Deciliter |
|
|
DLBCL |
diffuse large B-cell lymphoma |
|
|
DLBL |
Diffuse Large B-Cell Lymphoma |
|
|
DLCL |
Diffuse Large Cell Lymphoma |
|
|
DLCST |
Danish Lung Cancer Screening Trial |
|
|
DLS |
Date Last Seen |
|
|
DLT |
Dose Limiting Toxicity - determined by phase 1 studies |
|
|
DMC |
Data Monitoring Committee |
|
|
DNA |
Deoxyribose Nucleic Acid |
|
|
DNA |
Did Not Attend |
|
|
DNC |
Does Not Compete |
|
|
DNR |
Do Not Resusitate |
|
|
DNT |
Dysembryoplastic Neuroepithelial Tumor |
|
|
DO |
Doctor of Osteopathy |
|
|
DOA |
dead on arrival |
|
|
DOB |
Date Of Birth |
|
|
DOD |
Date Of Death |
|
|
DPC |
deleted in pancreatic cancer |
|
|
DR |
Doctor |
|
|
DR |
Doctor of Radiology |
|
|
DRG |
Diagnosis Related Group |
|
|
DRR |
Digitally Reconstructed Radiograph |
|
|
ds |
discharge summary |
|
|
ds |
Discharge status |
|
|
DSMC |
Data and Safety Monitoring Committee |
|
|
DTR |
Deep Tendon Reflex |
|
|
DUBTC |
Duke University Brain Tumor Center |
|
|
DWD |
Death With Dignity |
|
|
DX |
Diagnosis |
|
|
EACR |
European Association for Cancer Research |
|
|
EADO |
European Association of Dermato-Oncology |
|
|
EANO |
European Association of Neuro-Oncology |
|
|
EBC |
Early Breast Cancer |
|
|
EBI |
Electronic Battery Indicator |
|
|
EBM |
d'Evidence Based Medicine |
|
|
EBMT |
European Group for Blood and Marrow Transplantation |
|
|
EBNA |
Epstein Barr Nuclear Antigen |
|
|
EBV |
anti-Epstein Barr virus |
|
|
ECAA |
Esophageal Cancer Awareness Association |
|
|
ecan |
Esophageal Cancer Action Network |
|
|
ECC |
Embryonal Cell Carcinoma |
|
|
ECF |
Extended Care Facility |
|
|
ECG |
Electrocardiogram |
|
|
ECM |
Extra Cellular Mass |
|
|
ECOG |
Eastern Cooperative Oncology Group (U.S.) |
|
|
ECP |
erythroid committed precursors |
|
|
EDC |
Electrodesiccation and curettage |
|
|
EDTA |
Ethylene-Diamine-Tetra-Acetic acid |
|
|
EENT |
eyes ears nose and throat |
|
|
EFR |
European Federation for Colorectal Cancer |
|
|
EFS |
Event Free Survival - time from diagnosis to defined events (e.g. , relapse or death) |
|
|
EGD |
Esophagogastroduodenoscopy |
|
|
EI |
Erythroblastic islands |
|
|
EICESS |
European Intergroup Cooperative Ewing's Sarcoma Study |
|
|
EJC |
European Journal of Cancer |
|
|
EMC |
epithelial-myoepithelial carcinoma |
|
|
EMCT |
Ellen MacArthur Cancer Trust |
|
|
EMG |
Electromyogram |
|
|
EML4 |
Echinoderm Microtubule associated protein Like 4 |
|
|
EMN |
European Myeloma Network |
|
|
EMUO |
Early Morning Urine Osmolality (evaluating urine concentration) |
|
|
ENCR |
European Network of Cancer Registries |
|
|
ENL |
Enlarged |
|
|
ENSG |
European Neuroblastoma Study Group |
|
|
ENT |
Ear nose and throat |
|
|
ENT |
Ear, Nose, Throat |
|
|
EOI |
European Osteosarcoma Intergroup |
|
|
EONS |
European Oncology Nursing Society |
|
|
eortc |
European Organization for Research and Treatment of Cancer's |
|
|
EORTC |
European Organisation for Research and Treatment of Cancer |
|
|
EPA |
Erect, posterior, anterior |
|
|
EPC |
Endothelial Precursor Cells |
|
|
EPIC |
Expanded Prostate Cancer Index Composite |
|
|
EPP |
Environmentally Preferable Purchasing |
|
|
EQ |
Exceptional Quality |
|
|
ER |
Emergency Room |
|
|
ER(A) |
Estrogen receptor (assay) |
|
|
ERCP |
Endoscopic Retrograde Cholangio Pancreatography |
|
|
ESL |
Electro Science Laboratories |
|
|
ESO |
European School of Oncology |
|
|
ESPC |
Early Stage Prostate Cancer |
|
|
ESR |
Erythrocyte Sedimentation Rate |
|
|
EST |
Electroshock Therapy |
|
|
ESTRO |
European Society for Therapeutic Radiation and Oncology |
|
|
ETI |
Expanded Testing Initiative |
|
|
ETOH |
Ethyl Alcohol (Ethanol) |
|
|
ETS |
Environmental Tobacco Smoke |
|
|
EUA |
Exam Under Anesthesia |
|
|
EUSOMA |
European Society of Breast Cancer Specialists |
|
|
Exam |
Examination |
|
|
Exc |
Excision |
|
|
Exp Lap |
exploratory laparotomy |
|
|
EXT |
Extend, extension |
|
|
f |
Degrees Fahrenheit |
|
|
F(M)H |
Family (medical) history |
|
|
F/H |
Family History |
|
|
FAB |
French American and British Classification Scheme for Leukemia |
|
|
FABNO |
Fellow of the American Board of Naturopathic Oncology |
|
|
FARGO |
Foundation for Applied Research in Gastrointestinal Oncology |
|
|
FB |
Fb, fingerbreadth |
|
|
FBC |
Full Blood Count |
|
|
FBCH |
Follicular Basal Cell Hyperplasia |
|
|
FBS |
fasting blood sugar |
|
|
FCCC |
Fox Chase Cancer Center |
|
|
FCO |
Forum of Clinical Oncology |
|
|
FCRS |
Family Cancer Risk Service |
|
|
FDA |
Food Drug Administration |
|
|
FEC |
Fluorouracil, Ebirubicin, Cyclophosphamide |
|
|
FECS |
Federation of European Cancer Societies |
|
|
FEV |
Forced Expectorant Volume |
|
|
FFA |
For Further Appointment |
|
|
FFP |
freedom from progression rate |
|
|
FFP |
fresh frozen plasma |
|
|
FGR |
Gardner- Rasheed feline sarcoma viral oncogene homolog |
|
|
FHBG |
fluoro-3-[hydroxymethyl]butyl)guanine |
|
|
FHCI |
Florida Hospital Cancer Institute |
|
|
FHCRC |
Fred Hutchinson Cancer Research Center |
|
|
FIGO |
Federation of International of Gynecologists and Obstetricians |
|
|
FISH |
Fluorescence In Situ Hybridization |
|
|
FISH |
Flourescence In-Situ Hybridization |
|
|
FLU |
Influenza |
|
|
FLURO |
Fluoroscopy |
|
|
FMTC |
Familial Medullary Thyroid Carcinoma |
|
|
FNA |
fine needle aspiration biopsy |
|
|
FNAB |
Fine Needle Aspiration Biopsy |
|
|
FOM |
Floor of Mouth |
|
|
FORCE |
Focus on Rehabilitation and Cancer Education |
|
|
FORCE |
Facing Our Risk of Cancer Empowered |
|
|
FORDS |
Facility Oncology Registry Data Standards |
|
|
FOS |
Finkel Osteogenic Sarcoma |
|
|
fp |
Flat Plate |
|
|
FPG |
Fasting Plasma Glucose |
|
|
FRED |
First Response Early Detection |
|
|
FSH |
Follicular Stimulating Hormone |
|
|
FU |
Follow-Up |
|
|
fuo |
fever unknown origin |
|
|
FVC |
Forced Vital Capacity |
|
|
FX |
Frozen section |
|
|
FX |
Fracture |
|
|
G |
Gram (g) |
|
|
G-CSF |
Granulocyte Colony Stimulating Factor |
|
|
GA |
General Anesthetic |
|
|
GA |
Gastric Analysis |
|
|
GACE |
Gamers Against Cancer Edition |
|
|
GALT |
Gut-associated Lymphoid Tissue Cells |
|
|
GB |
Gallbladder |
|
|
GBM |
Glioblastoma Multiforme |
|
|
GC |
Granulosa Cell |
|
|
GCA |
Giant Cell Arteritis |
|
|
GCCR |
German Childhood Cancer Registry |
|
|
GCCR |
Georgia Comprehensive Cancer Registry |
|
|
GCCR |
Gulf Center for Cancer Registration |
|
|
GCIG |
Gynecologic Cancer Intergroup |
|
|
GCP |
Good Clinical Practice |
|
|
GCT |
germ-cell tumour |
|
|
GCT |
Giant Cell Tumor |
|
|
GE |
Gastroesophageal |
|
|
GEN |
Generalized |
|
|
GFR |
Glomerular Filtration Rate |
|
|
GGCC |
Golden Gate Cancer Center |
|
|
GI |
Gastrointestinal |
|
|
GICR |
Global Initiative for Cancer Registry |
|
|
GIST |
Gastro-Intestinal Stromal Tumor |
|
|
gm |
Gram |
|
|
GM-CSF |
granulocyte macrophage colony-stimulating factor |
|
|
GMC |
General Medical Council (UK) |
|
|
GOG |
Gynecologic Oncology Group |
|
|
GP |
General Practitioner |
|
|
GP |
Gradual Progression |
|
|
GPOH |
Gesellschaft fur Padiatrische Onkologie und Hamatologie (German Pediaatric Oncology Group) |
|
|
GPR |
Good Partial Remission |
|
|
GR |
Grade |
|
|
gRED |
Genentech Research and Early Development |
|
|
GSHO |
German Society Of Hematology And Oncology |
|
|
GU |
Genitourinary |
|
|
GU |
Genito Urinary |
|
|
GVHD |
Graft Versus Host Disease |
|
|
GY |
Grays (units of radiation) |
|
|
GYN |
Gynecology |
|
|
H&E |
Hematoxylin and Eosin (stain) |
|
|
H&P |
history and physical examination |
|
|
H/O |
History of |
|
|
H2O |
Water (vapor) |
|
|
HAART |
Highly Active Anti Retroviral Treatment |
|
|
HAC |
hepatic arterial chemotherapy |
|
|
HARP |
Health Assessment and Recovery Program |
|
|
Hb |
Haemoglobin |
|
|
HB |
Hemoglobin |
|
|
HBOC |
Hereditary Breast and Ovarian Cancer |
|
|
HBOC |
Hereditary breast–ovarian cancer |
|
|
HCC |
Hepatocellular Carcinoma Can |
|
|
HCC |
Hepatocellular Carcinoma Cell |
|
|
hcc |
Hepatocellular Carcinoma and Chronic |
|
|
HCC |
Hepatocellular Carcinoma (liver cancer) |
|
|
HCC |
Hepatocellular Carcinoma Current |
|
|
HCCP |
Harvard Center for Cancer Prevention |
|
|
HCCP |
Hereditary Cancer in Clinical Practice |
|
|
HCCP |
Huntsman Cancer Care Program |
|
|
HCG |
Human Chorionic Gonadotropin |
|
|
HCL |
Hairy Cell Leukemia |
|
|
HCO3 |
Bicarbonate |
|
|
HCRC |
Harvard Cancer Research Center |
|
|
HCT |
Hematocrit |
|
|
HCVD |
Hypertensive Cardiovascular Disease |
|
|
HD |
Hodgkin's Disease (lymphoma) |
|
|
HD |
Heart Disease |
|
|
HD |
High-Dose |
|
|
HDC |
High-Dose Chemotherapy |
|
|
HDM |
High-Dose Melphalan |
|
|
HER-2/NEU |
Protein related to Cancer |
|
|
HER2 |
Human Epidermal Receptor #2 |
|
|
HEV |
anti-hepatitis E virus |
|
|
HF |
hair follicle |
|
|
HGB |
Hemoglobin |
|
|
HHC |
Human Health Carcinogen |
|
|
HIAC |
Hepatic Intra-Arterial Chemotherapy |
|
|
HIC |
Hypermethylated in Cancer |
|
|
HIV |
Human Immunodeficiency Virus I |
|
|
HL |
Hyperpigmented Lesions |
|
|
HL-A |
Human Leukocyte Associated antigen |
|
|
HLA |
Human Leukocyte Antigen |
|
|
HN2 |
Nitrogen mustard |
|
|
HNC |
Head and Neck Cancer |
|
|
HNPCC |
Hereditary Nonpolyposis Colorectal Cancer |
|
|
HOCI |
Hematology Oncology Consultants Inc |
|
|
HOG |
Hoosier Oncology Group |
|
|
HOPA |
Hematology Oncology Pharmacy Association |
|
|
HOPE |
Helping Oncology Patients Excel |
|
|
HORM |
Hormone |
|
|
HOSP |
Hospital |
|
|
hpf |
high power field |
|
|
HPI |
History of Present Illness |
|
|
HPV |
Human Papilloma Virus |
|
|
HR |
Hour |
|
|
HR |
High Risk |
|
|
HRT |
Hormone Replacement Therapy (man-made drugs used to ease the symptoms of menopause) |
|
|
HSC |
Heart Stroke and Cancer |
|
|
HTLV |
human T-cell lymphotropic viruses |
|
|
HTLV-III |
Human T-lymphotrophic virus type III |
|
|
HTN |
Helping The Needy |
|
|
HVD |
Hypertensive Vascular Disease |
|
|
HX |
History |
|
|
Hx |
Medical History |
|
|
Hyst |
hysterectomy |
|
|
I |
Iodine |
|
|
I-131 |
Radioactive Iodine |
|
|
IACR |
International Association of Cancer Registries |
|
|
IACS |
Institute for Applied Cancer Science |
|
|
IAHO |
International Association for Hyperthermic Oncology |
|
|
IARC |
International Agency for Research on Cancer |
|
|
IASLC |
International Association For The Study Of Lung Cancer |
|
|
IBC |
Inflammatory Breast Cancer |
|
|
IBCC |
Instituto Brasileiro de Controle do Câncer |
|
|
IBS |
ImmunoBlastic Sarcoma |
|
|
IC |
Infusion Chemotherapy |
|
|
IC |
Infiltrating Carcinoma |
|
|
ICARE |
International Cancer Alliance for Research and Education |
|
|
ICBP |
International Cancer Benchmarking Partnership |
|
|
ICC |
Intercultural Cancer Council |
|
|
ICCC |
International Classification of Childhood Cancer |
|
|
ICCCPO |
International Confederation of Childhood Cancer Parent Organizations |
|
|
ICCG |
International Collaborative Cancer Group |
|
|
ICCPO |
Icelandic Childhood Cancer Parent Organisation |
|
|
ICCPP |
International Cancer Control Planning Partnership |
|
|
ICD |
International Classification of Diseases (coding system) |
|
|
ICDO |
International Classification of Diseases for Oncology (coding system) |
|
|
ICF |
Intercellular fluid |
|
|
ICFC |
In Concert for Cancer |
|
|
ICH |
International Conference of Harmonization |
|
|
ICIC |
International Cancer Information Center |
|
|
ICIS |
International Cancer Imaging Society |
|
|
ICISS |
Integrated Cancer Information and Surveillance System |
|
|
ICM |
Intercostal margin |
|
|
ICON |
Integrated Cancer Oncology News |
|
|
ICPO |
Icpoinstitute Of Cytology And Preventive Oncology |
|
|
ICR |
The Institute For Cancer Research |
|
|
ICRF |
Israel Cancer Research Fund |
|
|
ICRF |
Imperial Cancer Research Fund |
|
|
ICS |
Intercostal Space |
|
|
ICSG |
Iranian Cancer Support Group |
|
|
ICSN |
International Cancer Screening Network |
|
|
ICSP |
Irish Cervical Screening Programme |
|
|
ICT |
Induction chemotherapy |
|
|
ICT |
Immunoreactive ChemoTherapy |
|
|
ICU |
Intensive Care Unit |
|
|
IDCP |
Invasive Ductal Carcinoma of the Pancreas |
|
|
IDL |
Intermediate Density Lipoprotein |
|
|
IDTP |
Intensive Day Treatment Program |
|
|
IESS |
Intergroup Ewing's Sarcoma Study |
|
|
IFCP |
Institute for Cancer Prevention |
|
|
IFO |
Ifosfamide |
|
|
IG |
Immune Globulin |
|
|
Ihc |
Immunohistochemical |
|
|
IHSS |
Include in Home Supportive Services |
|
|
IHSS |
Improve the in Home Supportive Services |
|
|
IL2 |
Interleukin2 |
|
|
ILC |
Invasive Lobular Carcinoma |
|
|
Im |
Intramuscular Myxoma |
|
|
IM |
Intramuscular |
|
|
IMA |
Internal Mammary Artery |
|
|
IME |
Independent Medical Examination |
|
|
IMF |
International Myeloma Foundation |
|
|
IMP |
Impression |
|
|
IMRT |
Intensity-Modulated Radiotherapy |
|
|
IMSR |
Integrated Microscopy Shared Resource |
|
|
INCL |
Include |
|
|
IND |
Investigational New Drug |
|
|
inf |
infusion |
|
|
INF |
Infarction |
|
|
Inf |
Inferior |
|
|
INFA |
International Neurofibromatosis Association |
|
|
INFILT |
Infiltrating |
|
|
inj |
injection |
|
|
INR |
International Normalization Ratio |
|
|
INSS |
International Neuroblastoma Staging System |
|
|
Int Med |
internal medicine |
|
|
IOCA |
In Ovo Carcinogenicity Assay |
|
|
IOR |
Institute of Oncology Research |
|
|
IORA |
Iowa Oncology Research Association |
|
|
IP |
Inpatient |
|
|
IPI |
International Prognostic Index |
|
|
IPMT |
Intraductal Papillary Mucinous Tumor |
|
|
IPOS |
International Psycho-Oncology Society |
|
|
IPPB |
intermittent positive pressure breathing |
|
|
IPSO |
International Society of Pediatric Surgical Oncology |
|
|
IPSS |
International Prostate Symptom Score |
|
|
IPTR |
International Pancreas Traansplant Registry |
|
|
IRCAD |
Institutetut de Recherche contre les Cancers de l'Appareil Digestif |
|
|
IROC |
Imaging and Radiation Oncology Core |
|
|
ISBP |
International Society of Breast Pathology |
|
|
ISCC |
International Society for Children with Cancer |
|
|
ISCO |
International Society for Cellular Oncology |
|
|
ISCO |
Idaho Society of Clinical Oncology |
|
|
ISCR |
Indiana State Cancer Registry |
|
|
ISCR |
Illinois State Cancer Registry |
|
|
ISOO |
International Society of Oral Oncology |
|
|
ISRO |
Iranian Society of Radiation Oncology |
|
|
IST |
Istituto Scientifico Tumori |
|
|
IT |
Intrathecal |
|
|
ITC |
Isolated tumor cells |
|
|
ITCC |
Innovative therapies for children with cancer |
|
|
ITOG |
International Thyroid Oncology Group |
|
|
ITU |
Intensive Therapy Unit |
|
|
IV |
Intravenous |
|
|
IV |
Intravenous - into a vein |
|
|
IVC |
Interior |
|
|
IVP |
Intravenous Pyelogram |
|
|
IWMF |
International Waldenstrom's Maroglubulinemia Foundation |
|
|
jbcp |
Jordan Breast Cancer Program |
|
|
JCAN |
Japan Cancer Action Network |
|
|
JCO |
Journal of Clinical Oncology |
|
|
JCRB |
Japanese Collection of Research Bioresources |
|
|
JCRB |
Japanese Cancer Research Resources Bank |
|
|
JFCC |
Josephine Ford Cancer Center |
|
|
JHU |
The Johns Hopkins University (Baltimore, MD) |
|
|
JME |
Journal of Medical Ethics |
|
|
JNO |
Journal of Neuro-Oncology |
|
|
JVD |
Jugular Venous Distention |
|
|
K |
Potassium |
|
|
KCP |
Kentucky Cancer Program |
|
|
kg |
Kilogram |
|
|
KJ |
Knee Jerk |
|
|
KK |
Knee Kick |
|
|
KSHV |
Kaposi's Sarcoma-associated Herpes Virus |
|
|
kV |
Kilovolt (one thousand volts) (measurement) |
|
|
L |
Literature |
|
|
L |
Left |
|
|
L |
Liter |
|
|
L&W |
Living and Well |
|
|
L-SPINE |
Spine, Lumbar |
|
|
L1 - L5 |
Lumbar vertebrae 1 - 5 (spine eg. L1 = 1st lumbar vertebra) |
|
|
lab |
Laboratory Accreditation Board |
|
|
LAB |
Laboratory |
|
|
Lab |
Laboratory Animals Bureau |
|
|
lab |
Laboratory Assessments Board |
|
|
LAEC |
locally advanced esophageal cancer |
|
|
Lap |
Laparotomy |
|
|
Lat |
Lateral |
|
|
LAV |
Lymphadenopathy-Associated Virus |
|
|
LBICR |
Ludwig Boltzmann Institut for Cancer Research |
|
|
LCCG |
Lung Cancer Cooperative Group |
|
|
LCCL |
Lung Cancer Cell Lines |
|
|
LCDD |
Light Chain Deposition Disease |
|
|
LCDR |
Lung Cancer Death Rate |
|
|
LCh |
Langerhans Cell Histiocytocis |
|
|
LCH |
Langerhans Cell Histiocytosis |
|
|
LCIS |
Lobular Carcinoma in Situ |
|
|
LCIS |
Lobular carcinoma in-situ |
|
|
LCM |
Left Costal Margin |
|
|
LCRF |
Luminal CCK-Releasing Factor |
|
|
LCRI |
Lymphocyte Cytoplasmic Refractive Index |
|
|
Lcss |
Lung Cancer Symptom Scale |
|
|
LDH |
Lactic dehydrogenase -high levels correlate with tumour volume in some cancers |
|
|
LDH |
lactic dehydrogenase |
|
|
LE |
Left Eye |
|
|
LE |
Lupus Erythematosus |
|
|
LF |
laser fulguration |
|
|
LFCF |
Lewis Family Cancer Fund |
|
|
LFT |
Liver Function Test |
|
|
LG |
Large |
|
|
LGL |
Large Granular Lymphoma |
|
|
LH |
left hemisphere |
|
|
LHRH |
luteinizing hormone releasing hormone, luliberin |
|
|
LICAP |
Leeds Institute of Cancer and Pathology |
|
|
LIF |
Left Iliac Fossa |
|
|
LIF |
Leukemia Inhibitory Factor |
|
|
LINAC |
Linear Accelerator |
|
|
LIQ |
Lower Inner Quadrant |
|
|
LIT |
Leukocyte Immune Therapy |
|
|
LKS(B) |
Liver, kidney, spleen (bladder) |
|
|
LLE |
left lower extremity |
|
|
LLL |
left lower lobectomy |
|
|
LLQ |
left lower quadrant |
|
|
LMD |
Local Medical Doctor |
|
|
LMM |
Lentigo Maligna Melanoma |
|
|
LMOT |
Low Malignant Ovarian Tumor |
|
|
LMP |
Low Malignant Potential (context: ovarian tumours) |
|
|
LMP |
Last Menstrual Period |
|
|
LMP |
Low Malignant Potential |
|
|
LMS |
Leiomyosarcoma |
|
|
LN |
Lymph Node |
|
|
LNCC |
Ligue Nationale Contre le Cancer |
|
|
LND |
Lymph Node Dissection |
|
|
LOH |
low Loss of heterozygosity |
|
|
LOP |
Lower outer quadrant |
|
|
LOT |
Living Organic Tissue |
|
|
LP |
Lumbar Puncture |
|
|
LPF |
Low Power Field |
|
|
LPN |
Licensed Practice Nurse |
|
|
LPS |
Large Polyp Stony |
|
|
LRCP |
London Regional Cancer Program |
|
|
LREC |
Local Research Ethics Committee |
|
|
LRF |
Leukemia Research Fund |
|
|
LRFA |
Lymphoma Research Foundation of America |
|
|
LRM |
Litigation Risk Management |
|
|
LRO |
Leeward Radiation Oncology Cancer Treatment, |
|
|
LS |
Lumbosacral |
|
|
LSO |
Left Salpingo-Oophorectomy |
|
|
LT |
Left |
|
|
LTRA |
Leukotriene Receptor Antagonist |
|
|
LUE |
Left Upper Extremity |
|
|
LUL |
Left Upper Lobe |
|
|
LUQ |
Left Upper Quadrant |
|
|
LVEF |
Left Ventricular Ejection Fraction - a heart function test |
|
|
LVEF |
Left Ventricular Fjection Fraction |
|
|
LVSF |
Left Ventricular Shortening Fraction |
|
|
LVSF |
Left Ventricular Shortening Fraction - a heart function test |
|
|
LX |
Lumpectomy |
|
|
M |
Monocytes |
|
|
m |
micrometer |
|
|
m |
Meter |
|
|
M-CSF |
marrow-derived cytokine, macrophage colony-stimulating factor |
|
|
M/H |
Medical history |
|
|
MAb |
Maximal Androgen Blockade |
|
|
MAB - MAB |
Monoclonal antibody |
|
|
MABC |
Men Against Breast Cancer |
|
|
MAD |
Melanoma Awareness Day |
|
|
MAD |
Maximal Androgen Deprivation |
|
|
MAF |
Macrophage Activating Factor |
|
|
MAGE |
Melanoma AntiGEn |
|
|
MAGE |
melanoma antigen-encoding gene |
|
|
MAGE |
Melanoma Antigen Gene |
|
|
MAGIC |
Mucosta Against Gastric Inflammation Carcinogenesis |
|
|
MAL |
Malignant |
|
|
MALIG |
Malignant |
|
|
MALT |
Mucosa Associated Lymphoid Tumor |
|
|
MALT |
Mucosal Associated Lymphoid Tissue |
|
|
mand |
mandible |
|
|
MASCC |
Mulinational Association of Supportive Care in Cancer |
|
|
MAST |
Mastectomy |
|
|
MBBL |
Multiple Benign Breast Lesions |
|
|
MBC |
Male Breast Cancer |
|
|
MBCIS |
Multicultural Breast Cancer Information Service |
|
|
MBMC |
Myeloid Bone Marrow Cultures |
|
|
mc |
millicurie |
|
|
MCA |
Medicines Control Agency (U.K.) |
|
|
MCBO |
Molecular Cell Biology and Oncology Graduate Program |
|
|
MCCP |
Maine Childrens Cancer Program |
|
|
MCE |
Mammography Continuing Education |
|
|
MCGA |
Michigan Cancer Genetics Alliance |
|
|
MCH |
Mean Corpuscular Hemoglobin |
|
|
MCL |
Mid-Clavicular Line |
|
|
MCL |
Mononuclear Cell Leukemia |
|
|
MCL |
Mantle Cell Lymphoma |
|
|
MCMC |
Multidisciplinary Cancer Management Course |
|
|
MCP |
Modified Citrus Pectin |
|
|
MCR |
Molecular Cancer Research |
|
|
MCR |
Myeloablative Conditioning Regimen |
|
|
MCRA |
Minnesota Cancer Registrars Association |
|
|
MCRB |
Masonic Cancer Research Building |
|
|
MCRC |
Michigan Cancer Research Consortium |
|
|
MCT |
Molecular Cancer Therapeutics |
|
|
MCV |
Million electron volts |
|
|
MD |
moderately differentiated |
|
|
MDR |
Multi-drug-resistant |
|
|
MDS |
Myelo Dysplastic Syndrome |
|
|
MDS |
Myelodysplastic Syndrome |
|
|
MECC |
Middle East Cancer Consortium |
|
|
MED |
Medial |
|
|
MEF |
Mouse Embryonic Fibroblast |
|
|
MEL |
Melanoma |
|
|
MEN |
Multiple Endocrine Neoplasia Syndrome |
|
|
mEq/L |
milliequivalent per liter |
|
|
METS |
Metastases |
|
|
MF |
Mycosis Fungoides |
|
|
MFI |
Multiplex Fluorescent Immunoassay |
|
|
MG |
Magnesium |
|
|
MG |
milligram; 1/1000 gram |
|
|
MGHS |
Marquette General Health System |
|
|
MGUS |
Monoklonale Gammopathien Unbestimmter Signifikanz |
|
|
MH |
Marital History |
|
|
MH |
Mental Health |
|
|
MHF |
Michael Hoefflin Foundation |
|
|
MI |
Miocardial Infarction |
|
|
MIBC |
Muscle-invasive bladder cancer |
|
|
MIBG |
MetaIdoBenzoGuanidine |
|
|
micro |
microcytic, microscopic |
|
|
MIR |
Main Immunogenic Region |
|
|
ML |
Millilitre (0.001 Liter) |
|
|
ML |
milliliter; 1/1000 liter |
|
|
MLD |
Metachromatic Leukodystrophy Disease |
|
|
MLOH |
Main Line Oncology Hematology Associates |
|
|
MLV |
Murine Leukemia Virus |
|
|
MM |
Malignant Melanoma |
|
|
MM |
MeningoMyelocele |
|
|
mM |
millimolar (millimoles/liter) |
|
|
mm |
Millimeter |
|
|
mm |
MilliMeter (0.001 Meters) |
|
|
MM |
Multiple Myeloma (type of cancer) |
|
|
MM |
Millimole |
|
|
MMC |
Maximum Mass Concentration |
|
|
MMD |
minimal melanogenic dose |
|
|
MMMT |
Malignant Mixed Mesodermal Tumor |
|
|
MMRI |
Mater Medical Research Institute |
|
|
MMTR |
Madras Metropolitan Tumor Registry |
|
|
MMTV |
Mouse Mammary Tumor Virus |
|
|
MO |
Multiple osteochondromas |
|
|
MOD |
moderate dysplasia |
|
|
MOD DIFF |
Moderately differentiated |
|
|
MOPP |
Military Operational Protective Posture |
|
|
MOPP |
Mission Oriented Protective Pants |
|
|
MORE |
Mens Oncology Research Education |
|
|
MOSM |
Milliosmole |
|
|
MPCC |
Massachusetts Prostate Cancer Coalition |
|
|
MPD |
Myeloproliferative Disorder |
|
|
MPNST |
Malignant Peripheral Nerve Sheath Tumour |
|
|
MPO |
Medical and Pediatric Oncology (journal) |
|
|
MPO |
Medical and Pediatric Oncology |
|
|
MRC |
Medical Research Council |
|
|
MREC |
Multicentre Research Ethics Committee |
|
|
MREC |
Multi-centre Research Ethics Committee |
|
|
MRI |
Magnetic Resonance Imaging |
|
|
MRM |
Modified Radical Mastectomy |
|
|
MRT |
Malignant Rhabdoid Tumour |
|
|
MRT |
Matrix Regeneration Therapy |
|
|
MS |
Mitral Stenosis |
|
|
MSCO |
Minnesota Society of Clinical Oncology |
|
|
MSL |
Mid Sternal Line |
|
|
MSSU |
Mid Stream Specimen Urine |
|
|
MSTI |
Mountain States Tumor Institute |
|
|
MTC |
micromedullary thyroid carcinoma |
|
|
MTC |
Medullary Thyroid Carcinoma |
|
|
MTCI |
Molecular Therapeutics for Cancer Ireland |
|
|
MTD |
Maximum Tolerated Dose (that does not produce unacceptable toxicity) |
|
|
MTD |
Maximum Tolerated Dose - phase 1 studies |
|
|
MTOP |
Multidisciplinary Thoracic Oncology Program |
|
|
MTX |
Methotrexate (anticancer drug) |
|
|
MTX |
Methotrexate |
|
|
MUD |
Matched Urelated Donor - for bone marrow transplant |
|
|
MUD |
Matched Urelated Donor |
|
|
MX |
Mastectomy |
|
|
MX |
Microscopic |
|
|
mx |
maxilla |
|
|
N&V |
Nausea & Vomiting |
|
|
n/v |
nausea and vomiting |
|
|
Na |
Sodium (Latin ''Natrium'') |
|
|
NA |
Not Applicable |
|
|
NAACCR |
North American Association of Central Cancer Registries |
|
|
NABCO |
National Alliance of Breast Cancer Organizations |
|
|
NAD |
No Abnormality Detected |
|
|
NBCCS |
Nevoid Basal Cell Carcinoma Syndrome |
|
|
NBM |
Nil by Mouth |
|
|
NBS |
Normal Bowel Sounds |
|
|
NBSP |
NHS Breast Screening Programme |
|
|
NCAH |
Nonclassical Congenital Adrenal Hyperplasia |
|
|
NCCC |
National Cervical Cancer Coalition |
|
|
NCCF |
National Childhood Cancer Foundation |
|
|
NCCF |
National Children's Cancer Foundation |
|
|
NCCP |
National Cancer Control Programmes |
|
|
NCCS |
National Coalition For Cancer Survivorship |
|
|
NCCS |
National Cancer Centre Singapore |
|
|
NCGC |
Norwegian Cancer Genomics Consortium |
|
|
NCI |
National Cancer Institue |
|
|
NCI |
National Cancer Institute, USA |
|
|
NCIC |
National Cancer Institute of Canada's |
|
|
NCIC |
National Cancer Institutetute of Canada |
|
|
NCL |
Nanotechnology Characterization Laboratory |
|
|
NCMT |
Non Cancerous Match Tissue |
|
|
NCRA |
National Cancer Registrars Association |
|
|
NCRI |
National Cancer Registry Ireland |
|
|
NCRM |
National Cancer Registry Of Malaysia |
|
|
NCSD |
National Cancer Survivors Day |
|
|
NCTN |
National Cancer Trials Network |
|
|
NDA |
New Drug Application |
|
|
NDCR |
North Dakota Cancer Registry |
|
|
NDPSA |
non-detectable PSA |
|
|
NDROC |
North Dallas Radiation Oncology Center |
|
|
NDSO |
Nasolacrimal Drainage System Obstruction |
|
|
NEC |
not elsewhere classified |
|
|
NECCR |
North of England Children's Cancer Research Unit |
|
|
NED |
no evidence of disease |
|
|
Neg |
NEGative |
|
|
Neuro |
Neurology |
|
|
ng |
Nanogram |
|
|
NHB |
Neoadjuvant Hormone Blockage |
|
|
NHL |
Non Hodgkin Lymphoma |
|
|
NHL |
Non-Hodgkin's Lymphoma |
|
|
NHT |
Neoadjuvant Hormone Therapy |
|
|
NICR |
Northern Institute for Cancer Research |
|
|
NICR |
Northern Ireland Cancer Registry |
|
|
NIDS |
Neuro Immune Dysfunction Syndrome |
|
|
NK |
Not Known |
|
|
NK |
Natural Killer |
|
|
NKCA |
National Kidney Cancer Association |
|
|
NKI-AVL |
Nederlands Kanker Instituut - Antoni van Leeuwenhoek Ziekenhuis |
|
|
NKT |
Natural killer T-cells |
|
|
NL |
normal language |
|
|
nl |
Normal |
|
|
NLCP |
National Lung Cancer Partnership |
|
|
NLP |
Neuro-Linguistic Programming. A modern scientific model for communication and self-development. See the NLP section for more information. 'Neuro' refers to the way your brain and senses, interprets and process your experiences. 'Linguistic' refers to the |
|
|
NM |
Nodular melanoma |
|
|
NMC |
non-medullary carcinoma |
|
|
NMR |
Nuclear Magnetic Resonance |
|
|
NMS |
Non-Melanoma Skin |
|
|
NMSC |
Non-Melanoma Skin Cancer |
|
|
NNFF |
National Neurofibromatosis Foundation |
|
|
NOCR |
Network For Oncology Communication and Research |
|
|
NOEP |
Nurse Oncology Education Program |
|
|
NORD |
National Organization for Rare Disorders, Inc. |
|
|
NOS |
Not Otherwise Specified |
|
|
NP |
Narayan prediction |
|
|
NPC |
Nasopharyngeal Carcinoma |
|
|
NPCP |
National Prostate Cancer Project |
|
|
NR |
Not Recorded |
|
|
NR |
Not reportable |
|
|
NRCI |
Northeast Regional Cancer Institute |
|
|
NRCT |
National Registry of Childhood Tumours, CCRG at Oxford |
|
|
NRCT |
National Register of Cancer Trials |
|
|
NRCT |
National Registry of Childhood Tumours |
|
|
NRK |
Normal Rat Kidney Cell |
|
|
NRSTS |
Non-Rhabdomyosarcoma Soft Tissue Sarcoma |
|
|
NRSTS |
nonrhabdomyosarcoma soft tissue sarcoma |
|
|
NSA |
No Significant Abnormalities |
|
|
NSCLC |
Non Small Cell Lung Cancer |
|
|
NSE |
neuron-specific enolase |
|
|
NSE |
anti-neuron specific enolase |
|
|
NSF |
No Significant Findings |
|
|
NSHOA |
North Shore Hematology Oncology Associates |
|
|
NSLC |
non-small cell lung carcinoma |
|
|
NSR |
Non-Significant Result |
|
|
NSR |
Normal Sinus Rhythm |
|
|
NSR |
No Sign of Recurrence |
|
|
NSR |
Normal Sinus Rhythem |
|
|
NSR |
Non Significant Result |
|
|
NTP |
normal temperature and pressure |
|
|
NVD |
Neck Vein Distention |
|
|
NWCR |
North West Cancer Research |
|
|
O/E |
On Examination |
|
|
OASIS |
Ovarian Awareness, Support, Involvement, and Survivorship |
|
|
OATU |
oncology acute toxicity unit |
|
|
OB |
obstetrics |
|
|
obst |
obstructed |
|
|
OCAN |
Ovarian Cancer Awareness Network |
|
|
OCBN |
Ontario Cancer Biomarker Network |
|
|
OCCA |
Oklahoma Children's Cancer Association |
|
|
OCCR |
Ovarian Cancer Cluster Region |
|
|
OCEAN |
The Ovarian Cancer Education Awareness Network |
|
|
OCF |
Orange County Foundation for Oncology |
|
|
OCF |
Oncology Computing Facility |
|
|
OCMU |
Oncology Center Mansoura University |
|
|
OCN |
Oncology Certified Nurse |
|
|
OCNA |
Ovarian Cancer National Alliance |
|
|
OCRA |
ohio cancer registrars association |
|
|
OCRF |
Ovarian Cancer Research Fund |
|
|
OCS |
Office of Cancer Survivorship |
|
|
OCSA |
Ovarian Cancer Symptom Awareness |
|
|
OCTO |
Oncology Clinical Trials Office |
|
|
OD |
Oligodendrogliomas |
|
|
OD |
Ollier Disease |
|
|
OD |
OverDose |
|
|
OECI |
Organisation of European Cancer Institutes |
|
|
OECI |
Organization of European Cancer Institutes |
|
|
OH |
Occupational History |
|
|
OHC |
Oncology Hematology Care |
|
|
OHNC |
Oral Head and Neck Cancer |
|
|
OKC |
Odontogenic Keratocysts Chryotherapy |
|
|
ONB |
Olfactory NeuroBlastoma |
|
|
ONC |
Oncology Nurse Certified |
|
|
Onc |
ONCology |
|
|
OODP |
Office of Oncology Drug Products |
|
|
OOG |
Ophthalmic Oncology Group |
|
|
OORL |
Oncology Outcomes Research Laboratory |
|
|
OP |
Out-Patient |
|
|
OP |
Outpatient |
|
|
OP |
Operational |
|
|
OP |
Oncotic pressure |
|
|
OPC |
out-patient care |
|
|
OPD |
Outpatient clinic department |
|
|
OPHTH |
Ophthalmology |
|
|
OPMAS |
Oncology Patient Management Audit System |
|
|
OR |
Operating Room |
|
|
ORCH |
orchiectomy |
|
|
ORP |
Oncology Research Program |
|
|
orth |
ortho orthopedics, orthopedic |
|
|
OS |
Osteogenic Sarcoma (bone tumors) |
|
|
OS |
Overall Survival |
|
|
OS |
osteogenic sarcoma |
|
|
OSCR |
Oncology Symptom Control Research |
|
|
OSM |
Oncostatin M |
|
|
Osteo |
Osteomyelitis |
|
|
OT |
Occupational Therapy |
|
|
OTN |
Oncology Therapeutics Network |
|
|
Oto |
Otology |
|
|
OTRU |
Ontario Tobacco Research Unit |
|
|
OU |
each eye |
|
|
OV |
Office Visit |
|
|
OVCAD |
OVarian CAncer Diagnosis |
|
|
OWR |
One Woman's Reconstruction |
|
|
OZ |
Ounce |
|
|
P |
Pulse |
|
|
P&A |
Percussion and Auscultation |
|
|
PA |
Pulmonary Artery |
|
|
pa |
posteroanterior |
|
|
PAACT |
Patient Advocates for Advancement in Cancer Therapy |
|
|
PAC |
Partners Against Cancer |
|
|
PACM |
Presumed asbestos cancerous materials |
|
|
PALP |
Palpable |
|
|
PALS |
Pediatric Advanced Life Support |
|
|
PAP |
Prostatic Acid Phosphatase |
|
|
Pap |
Papanicolaou test (pap smear) |
|
|
pap |
papillary adenocarcinoma |
|
|
PAP |
Papanicolaou |
|
|
PAR |
Post anesthesia room |
|
|
PARA |
Number of pregnancies resulting in viable infants |
|
|
PASRR |
Pre-Admission Screening and Resident Review |
|
|
PAT |
Physical Ability Test |
|
|
Path |
Pathology |
|
|
PBCE |
Placer Breast Cancer Endowment |
|
|
PBCI |
Palm Beach Cancer Institute |
|
|
PBSC |
Peripheral Blood Stem Cell |
|
|
PBSCH |
Peripheral Blood Stem Cell Harvest |
|
|
PBSCR |
Peripheral Blood Stem Cell Rescue |
|
|
PBSCR |
Peripheral Blood Stem Cell Rescue (transplant) |
|
|
PBSCT |
Peripheral Blood Stem Cell Transplant |
|
|
PBTR |
Pediatric Brain Tumor Research |
|
|
PBTRI |
Pediatric Brain Tumor Research Institute |
|
|
PC |
Prostate Cancer |
|
|
PC |
Pancreas Cancer |
|
|
PCa |
Prostate Cancer |
|
|
PCAN |
Pediatric Cancer Action Network |
|
|
PCD |
Prostate Cancer Digest |
|
|
PCF |
Prostate Cancer Fdn |
|
|
PCOP |
Prostate Cancer Options Program |
|
|
PCOS |
Prostate Cancer Outcomes Study |
|
|
PCOS |
Polycystic Ovarian Syndrome |
|
|
PCP |
President's Cancer Panel |
|
|
PCPT |
Prostate Cancer Prevention Trial |
|
|
PCR |
Prostate Cancer Research |
|
|
PCR |
Pediatric Cancer Research |
|
|
PCRF |
Pediatric Cancer Research Foundation |
|
|
PCRM |
Physicians Committee for Responsible Medicine |
|
|
PCTG |
Prostate Cancer Treatment Guide |
|
|
PCV |
packed cell volume (of blood) |
|
|
PD |
poorly differentiated |
|
|
PD |
Progressive Disease |
|
|
PDQ |
Physician's Data Query |
|
|
PDR |
Physician’s Desk Reference |
|
|
PDT |
Photodynamic Therapy |
|
|
PE |
Physical Examination |
|
|
PEG |
Pneumoencephalography |
|
|
PET |
Pancreatic Endocrine Tumor |
|
|
PET |
positron emission tomography |
|
|
PFS |
Progression Free Survival |
|
|
Ph |
Past History |
|
|
PH |
Power of Hydrogen (hydrogen-ion concentration) |
|
|
PHAT |
Pleomorphic Hyalinizing Angiectatic Tumor |
|
|
PHC |
Primary Hepatocellular Carcinoma |
|
|
PHLA |
Post-Heparin Lipolytic Activity |
|
|
PI |
Present Illness |
|
|
PICC |
Perspectives In Colorectal Cancer |
|
|
PID |
pelvic inflammatory disease |
|
|
PIE |
Post-Irradiation Examination |
|
|
PIN |
Prostatic Intraepithelial Neoplasia |
|
|
PIN |
prostatic intraductal neoplasia |
|
|
PIOS |
Point In Oncogene Synthesis |
|
|
PLB |
Primary Lymphoma of Bone |
|
|
PLCO |
Prostate, Lung, Colorectal, Ovarian |
|
|
PLL |
Prolymphocytic leukaemia |
|
|
PLT |
Platelet |
|
|
PM |
Post Mortem |
|
|
PMD |
Personal medical doctor |
|
|
PMH |
Past Medical History |
|
|
PML |
PolyMorphonuclear Leukocytes |
|
|
Pnd |
Postnasal Drip |
|
|
PNET |
peripheral neuroectodermal tumour |
|
|
PNET |
primitive neuroectodermal tumour |
|
|
pnet |
Primitive NeuroEctodermal Tumor |
|
|
PNET |
Peripheral NeuroEctodermal Tumor (Bone tumors) |
|
|
PNs |
Peripheral Nervous Systems |
|
|
PO |
postoperative |
|
|
POB |
Preventive Oncology Board |
|
|
POCC |
Power Over Cervical Cancer |
|
|
POCM |
peritoneal ovarian cancer metastases |
|
|
POCR |
Principles of Oncology for Cancer Registry |
|
|
POD |
Postoperative Day |
|
|
POE |
Pediatric Oncology Education |
|
|
POG |
Pediatric Oncology Group |
|
|
POGO |
Pediatric Oncology Group of Ontario |
|
|
POKEMON |
POK Erythroid Myeloid Ontogenic Factor |
|
|
POND |
Pediatric Oncology Network Database |
|
|
PONF |
Paediatric Oncology Nurses Forum |
|
|
POOR DIFF |
poorly differentiated |
|
|
POR |
Post Operative Recovery |
|
|
POR |
Pathology and Oncology Research |
|
|
PORT |
Pediatric Oncology Resource Team |
|
|
POS |
Positive |
|
|
POSS |
Possible |
|
|
post |
Posterior |
|
|
POSTOP |
Postoperative |
|
|
PP |
Partin prediction |
|
|
PPA |
Per Prokura |
|
|
PPCC |
Pennsylvania Prostate Cancer Coalition |
|
|
PPD |
Purified Protein Derivative |
|
|
PPD |
Packs Per Day |
|
|
PPO |
Preferred provider organization |
|
|
ppt |
parts per trillion (1012) |
|
|
PQL |
Practical Quantitation Limit |
|
|
PR |
Partial Responce |
|
|
PR |
Partial Remission |
|
|
PR |
Per Rectum |
|
|
PR(A) |
Progesterone receptor (assay) |
|
|
PREOP |
Preopeartive |
|
|
PRL |
Prolactin |
|
|
prob |
probably |
|
|
PSA |
Prostatic specific antigen |
|
|
PSA |
Prostate-Specific Antigen |
|
|
PSA RT-PCR |
PSA reverse transcriptase-polymerase chain reaction |
|
|
Psadt |
Psa Doubling Time |
|
|
PSAV |
PSA velocity |
|
|
PSCR |
Peripheral Stem Cell Rescue |
|
|
PSCT |
peripheral stem cell transplant |
|
|
PSm |
prostate-specific membrane glycoprotein |
|
|
PSMA |
Prostate Specific Membrane Antigen Based |
|
|
PSU |
Pathogen Sequencing Unit |
|
|
PT |
Patient |
|
|
PT |
Physical Therapy |
|
|
PTA |
Prior To Admission |
|
|
PTCM |
Purified Tumor Cell Membrane |
|
|
PTEN |
Phosphatase/Tensin homolog deleted on chromosome 10 |
|
|
PTI |
Prostate Tumor Inducer |
|
|
PTML |
Peripheral T-Malignant Lymphoma |
|
|
PTPR |
Papillary Tumor of the Pineal Region |
|
|
PTU |
Preliminary Treatment Unit |
|
|
PTV |
Planning Target Volume |
|
|
PTX |
Paclitaxel |
|
|
PUD |
Peri-Urethral Diathermy |
|
|
Pulm |
pulmonary |
|
|
PUO |
Pyrexia of undermined origin |
|
|
PV |
prostate volume |
|
|
PV |
Polycythemia Vera |
|
|
PVR |
Party Versus Radicals |
|
|
PZE |
PaZElliptine |
|
|
PZI |
Protamine Zinc Insulin |
|
|
Q |
Quadrant |
|
|
QALY |
Quality Adjusted Life Year gained |
|
|
QCW |
Quantification Cytogenetic Workstation |
|
|
QGE |
Quantitative Genetic Epidemiology |
|
|
QO |
Quality Oncology, Inc. |
|
|
QOL |
Quality of Life |
|
|
R |
Roentgen |
|
|
R |
Right |
|
|
R |
Respirations |
|
|
R-S |
Reed-Sternberg cells |
|
|
R-V |
Rectovaginal |
|
|
RA |
Radium |
|
|
RACE |
Rally Against Cancer Expenses |
|
|
RAD |
Reactive Airway Disease |
|
|
RAD |
Radical |
|
|
RAIU |
Radioactive iodine uptake |
|
|
RALP |
Robotic-Assisted Laparoscopic Radical Prostatectomy |
|
|
RBC |
Red Blood Cell |
|
|
RBC |
Red Blood Cells |
|
|
RBC |
Red Blood Count |
|
|
RCC |
Renal Cell Carcinoma |
|
|
RCE |
Rare Cancers Europe |
|
|
RCG |
Radiology Consulting Group |
|
|
RCIT |
Radiation and Cancer Immunotherapy Theme |
|
|
RCM |
Right Costal Margin |
|
|
RCOP |
Rural Cancer Outreach Program |
|
|
RCS |
Reticulum Cell Sarcoma |
|
|
RCT |
randomised controlled trial |
|
|
RCT |
randomized controlled trial |
|
|
RCT |
Reliable Cancer Therapies |
|
|
REAL |
Revised European American Lymphoma |
|
|
REG |
Radioencephalogram |
|
|
REHAB |
Re-Habilitative Therapy |
|
|
REHEX |
Regional Human Exposure |
|
|
RER |
Research Expenditure Report |
|
|
RES |
Reticuloendothelial System |
|
|
RESEC |
Resection |
|
|
RESPIR |
Respiratory |
|
|
RF |
Right Front |
|
|
RFCC |
Rede Feminina de Combate ao Câncer |
|
|
RFS |
Recurrence-free survival |
|
|
RFS |
Relapse-Free Survival |
|
|
Rh |
Rhesus factor |
|
|
RIA |
Radioactive Immunoassay |
|
|
RIA |
Radio Immuno-Assay |
|
|
RICR |
Rhode Island Cancer Registry |
|
|
RICR |
radiation induced cancer risk |
|
|
Rif |
Right Iliac Fossa Pain |
|
|
RIGS |
Radioimmunoguided Surgery |
|
|
RIL |
Intravenous rInterleukin-2 |
|
|
RIQ |
Right inner quadrant |
|
|
RIS |
Radiological Information System |
|
|
RIT |
Radioimmunotherapy |
|
|
RITA |
Radiofrequency Interstitial Tumor Ablation |
|
|
RLE |
Right Lower Extremity |
|
|
RLL |
right lower lobe (lung) |
|
|
RLQ |
Right inner quadrant |
|
|
RLRC |
Rose Lake Research Center |
|
|
RMCC |
Rocky Mountain Cancer Centers |
|
|
RMGO |
Rocky Mountain Gynecologic Oncology |
|
|
RML |
right middle lobe (lung) |
|
|
RMS |
Rhabdomyosarcoma |
|
|
RN |
Registered Nurse |
|
|
RNA |
Ribo Nucleic Acid |
|
|
RNU |
Radiology-Nuclear Medicine |
|
|
RNV |
Radio- Nuclear Ventriculography |
|
|
RO |
Rule Out |
|
|
RoC |
Report on Carcinogens |
|
|
ROCK |
Reaching Out to Cancer Kids |
|
|
ROF |
Review of Outside Films |
|
|
ROIO |
Record Of Indeterminate Origin |
|
|
ROLL |
Radioguided Occult Lesion Localization |
|
|
ROM |
Range Of Motion |
|
|
ROQ |
Radiation Oncology Queensland |
|
|
ROQ |
Right Outer Quadrant |
|
|
ROS |
Review of Outside Slides |
|
|
ROSP |
Radiation Oncology Sciences Program |
|
|
RP |
Radical Prostatectomy |
|
|
RPCI |
Roswell Park Cancer Institute |
|
|
RPP |
Radical Perineal Prostatectomy |
|
|
RRD |
Recurrence Rate Data |
|
|
RRP |
radical retropubic prostatectomy |
|
|
RS |
Reed-Sternberg cells |
|
|
RSIS |
Radiology Scheduling/Inventory System |
|
|
RSO |
right salpingo-oophorectomy |
|
|
RT |
Right |
|
|
RT |
Radiation Therapy |
|
|
RT |
Radiotherapy |
|
|
RT-PCR |
reverse transcriptase polymerase chain reaction SC |
|
|
RTPCR |
Reverse Transcriptase Polymerase Chain Reaction |
|
|
RUE |
Right Upper Extremity |
|
|
RUL |
Right Upper Lobectomy |
|
|
RUQ |
Right Upper Quadrant |
|
|
RVG |
Radionuclide Ventriculogram |
|
|
RX |
prescriptions |
|
|
RX |
Treatment |
|
|
Rxt |
Radiation Xray Therapy |
|
|
S-SPINE |
Spine, Sacral |
|
|
S/P |
Status Post |
|
|
S1-S5 |
Sacral vertebra |
|
|
SA |
Surface Area |
|
|
SACT |
Systemic Anti Cancer Therapy |
|
|
SAE |
Serious Adverse Event |
|
|
SAOC |
South African Oncology Consortium |
|
|
SARC |
Sarcoma Alliance for Research through Collaboration |
|
|
SASMO |
South African Society of Medical Oncology |
|
|
SB |
Small Bowel |
|
|
SBE |
Subacute Bacterial Endocarditis |
|
|
SBMT |
Syngeneic Bone Marrow Transplantation |
|
|
SC |
Subcutaneous |
|
|
SCAL |
Service Controlled Agile Logistics |
|
|
SCAPE |
Skin Cancer Awareness Protection and Education |
|
|
SCAR |
Surviving Cancer Absolute Reality |
|
|
SCARE |
Skin Cancer Awareness Requires Education |
|
|
SCC |
Strategic Cell Controller |
|
|
SCC |
Squamous Cell Carcinoma |
|
|
SCC |
Short Course Chemotherapy |
|
|
SCCA |
Seattle Cancer Care Alliance |
|
|
SCCCC |
Smith County Comprehensive Cancer Coalition |
|
|
SCFL |
Secondary Cutaneous Follicular Lymphoma |
|
|
SCL |
Stem Cell Leukemia |
|
|
SCLC |
Small Cell Lung Cancer |
|
|
SCRN |
Sociobehavioural Cancer Research Network |
|
|
SCRN |
Scottish Cancer Research Network |
|
|
SCTN |
Scottish Cancer Therapy Network |
|
|
SD |
Stable Disease |
|
|
SDF |
Stromal Derived Factor |
|
|
SDV |
Source Data Verification |
|
|
SEER |
Surveillance, Epidemiology, and End Results |
|
|
SFOG |
Société Française d'Oncologie Gynécologique |
|
|
SFOP |
Société Française d'Oncologie Pédiatrique |
|
|
SFOP |
French Paediatric Oncology Society |
|
|
sfop |
French Paediatric Oncology Scociety |
|
|
SFPO |
Société Française de Pharmacie Oncologique |
|
|
SG |
Salivary Gland Carcinoma |
|
|
SGDM |
Study Group on Data Management |
|
|
SGO |
Society of Gynecologic Oncologists |
|
|
SGOT |
Serum Glutamic-Oxaloacetic Transaminase |
|
|
SGOT |
Serum Glutamic-oxalacetic Transaminase |
|
|
SGPT |
Serum hepatitis |
|
|
SH |
Social History |
|
|
SH |
Serum Hepatitis |
|
|
SHO |
Senior house officer (UK) |
|
|
SI |
Seed Implantation |
|
|
SIADH |
Syndrome of Inappropriate Antidiuretic Hormone |
|
|
SIADH |
Syndrome of Inappropriate Anti-Diuretic Hormone |
|
|
SIL |
Squamous Intraepithelial Lesion |
|
|
SIOP |
Société Internationale d'Oncologie Pédiatrique |
|
|
SIOP |
International Society of Paediatric Oncology |
|
|
slc |
Small cell Lung Carcinoma |
|
|
SM |
Small Medium |
|
|
SM |
Small |
|
|
SMAC |
Sock Monkeys Against Cancer |
|
|
SMF |
Standard Mammogram Form |
|
|
sml |
S&P Small Cap 600 Index |
|
|
SML |
Small |
|
|
SML BWL |
Small bowel |
|
|
SMOC |
Southeastern Medical Oncology Center |
|
|
SNF |
Skilled Nursing Facility |
|
|
SNLG |
Scottish and Newcastle Lymphoma Group |
|
|
SNP |
Single Nucleotide Polymorphismen |
|
|
SO |
salpingo-oophorectomy |
|
|
SOB |
Short of breath |
|
|
SOD |
Septo-Optic Dysplasia |
|
|
SOL |
Space-Occupying Lesion |
|
|
SOL |
Solution |
|
|
SOSAP |
Surgical Oncology Self-Assessment Program |
|
|
SP GR |
Specific Gravity |
|
|
SPEM |
Spasmolytic Polypeptide Expressing Metaplasia |
|
|
SPOHNC |
Support for People with Oral and Head and Neck Cancer |
|
|
SQ |
Subcutaneous |
|
|
Sq |
SQuamous |
|
|
SR |
Sedimentation Rate |
|
|
SSM |
Superficial spreading melanoma |
|
|
SSMM |
Superficial Spreading Malignant Melanoma |
|
|
SSO |
Society of Surgical Oncology |
|
|
SSRI |
Selective Seratonin Reuptake Inhibitor |
|
|
STAPH |
Staphylococcus aureus |
|
|
STAR |
Sharing Treatment and Recovery |
|
|
STAT |
Immediately (from Latin statim) |
|
|
STCR |
Society for Translational Cancer Research |
|
|
Strep |
Streptococcus |
|
|
STRST |
Thermal Stress Restrained Specimen Test |
|
|
STSG |
Split Thickness Skin Graft |
|
|
SubQ |
Subcutaneous |
|
|
surg |
Surgery |
|
|
SV |
Start Value |
|
|
SV |
Splice Variant |
|
|
SVC |
Superior Vena Cava |
|
|
SVCP |
Special Virus Cancer Program |
|
|
SWOG |
Southwest Oncology Group |
|
|
SX |
syndrome X |
|
|
SXD |
Self-eXamining Device |
|
|
SXM |
Self-eXamining Mechanism |
|
|
SzS |
Sézary Syndrome |
|
|
T |
Thoracic |
|
|
T |
Temperature |
|
|
t |
Tetraploid |
|
|
t |
Testosterone |
|
|
T&A |
Tonsillectomy and Adenoidectomy |
|
|
T-SPINE |
Spine, Thoracic |
|
|
T1 - T12 |
Thoracic vertebrae 1-12 (spine eg. T10 = tenth thoracic vertebra) |
|
|
ta |
Toxin-antitoxin |
|
|
TAA |
anti-tumor associated antigen |
|
|
TAB |
Tumors Accidents and Burns |
|
|
TAB |
Total Androgen Blockade |
|
|
TABC |
Tennis Against Breast Cancer |
|
|
TACE |
TNF-a Converting Enzyme |
|
|
TAH |
Total Abdominal Hysterectomy |
|
|
TAH-BSO |
Total abdominal hysterectomy- bilateral salpingo-oophorectomy |
|
|
TARG |
Technology And Application Resource Group |
|
|
TAT |
Tyrosinal Adrenal Thyroid |
|
|
TAT |
Targeted Anticancer Therapies |
|
|
TB |
Tuberculosis |
|
|
TBI |
total body irradiation |
|
|
TC |
Testicular Cancer |
|
|
Tc |
thyroid cancer |
|
|
TC |
Target cell |
|
|
TCC |
Transitional Cell Carcinoma |
|
|
TCIF |
Translational Cancer Imaging Facility |
|
|
TCOG |
Taiwan Cooperative Oncology Group |
|
|
TCP |
ThromboCytoPenia |
|
|
TCRN |
TIES Cancer Research Network |
|
|
TCRN |
Translational Cancer Research Network |
|
|
TCTP |
Translationally-Controlled Tumor Protein |
|
|
TD |
Tumor dose |
|
|
TEAM |
Testicular Educational Awareness For Men |
|
|
tetra |
Tetraploid |
|
|
TGF |
Tumor Growth Factor |
|
|
THP1 |
Tamm-Horsfall Protein 1 |
|
|
Ti |
Tumor Inducing |
|
|
TID |
Ter In Die (Three times a day) |
|
|
TIL |
Tumor Infiltrating Lymphocytes |
|
|
TIQ |
Therapy Impact Questionnaire |
|
|
TLC |
Tender Loving Care |
|
|
TLC |
Tumescent Liposuction Contouring |
|
|
TLI |
trypsin-like immunoreactivity |
|
|
TLS |
Tumor Lysis Syndrome |
|
|
TNB |
Transthoracic Needle Biopsy |
|
|
TNCS |
Third National Cancer Survey |
|
|
TNF |
Tumor Necrosis Factor |
|
|
TNF |
anti-tumour necrosis factor |
|
|
TNF-a |
Tumor Necrosis Factor alpha |
|
|
TNM |
Tumor Nodes Metastasis |
|
|
TNM |
Tumor, Noes, and Metastasis (Staging System - Primary Tumor) |
|
|
tnm |
Staging system |
|
|
TnT |
Transient Nuclear Test |
|
|
TOA |
The One At |
|
|
TOPS |
Teenage Oncology Patient Support |
|
|
TP |
Total Protein |
|
|
TPN |
Total Parenteral Nutrition |
|
|
TRACY |
Tracy Remembered And Cancer Yield |
|
|
TRAIL |
Tumor Necrosis Factor-related Apoptosis-inducing Ligand |
|
|
TRCC |
The Regional Cancer Center |
|
|
TREC |
Transdisciplinary Research on Energetics and Cancer |
|
|
TRI |
Tubulo Reticulo Inclusion |
|
|
trk |
TRansKetolase |
|
|
TROG |
Tasman Radiation Oncology Group |
|
|
TRP |
Tumor Repressor Protein |
|
|
TRP |
Transient Receptor Potential |
|
|
TRUS |
Transrectal Ultrasound |
|
|
TRUS-P |
Transrectal Ultrasound Of The Prostate |
|
|
TRUSP |
Transrectal Ultrasound of the Prostate |
|
|
TS |
tumor size |
|
|
TSG |
tumor suppressor gene(s |
|
|
TSS |
Therapeutic Staff Support |
|
|
TST |
Tuberculin Skin Test |
|
|
TTND |
Time To Non-detectable |
|
|
TTS |
Tumour Targeted Superantigens |
|
|
TTS |
Transdermal Therapeutic System |
|
|
TTT |
Tibial Tubercle Transfer |
|
|
TUR |
Transurethral Resection |
|
|
TURB |
Transurethral resection - Bladder |
|
|
TuRBT |
Transurethral resection of bladder tumour |
|
|
TURP |
Transurethral resection - Prostate |
|
|
TV |
Tumor Volume |
|
|
TVCN |
Thames Valley Cancer Network |
|
|
TVH |
Total Vaginal Hysterectomy |
|
|
TWAC |
The World Against Cancer |
|
|
TX |
Treatment (medical) |
|
|
TXT |
The Xtermination Team |
|
|
Tz |
Transition Zone |
|
|
TZB |
Tumor Zentrum Berlin |
|
|
U&ES |
Urea and Electrolytes |
|
|
U&Es |
Urea and Electrolites |
|
|
UA |
UrinAnalysis |
|
|
UAS |
Upstream Activator Sequence |
|
|
UCC |
Unicorns Causing Cancer |
|
|
UCHD |
Usual Childhood Diseases |
|
|
UE |
Upper Extremity |
|
|
UGI |
Upper Gastrointestinal |
|
|
UICC |
Union Internationale Contre le Cancer - International Union Against Cancer |
|
|
UIP |
Unconventional Innovations Program |
|
|
UIQ |
Upper-Inner Quadrant |
|
|
UKACR |
United Kingdom Association of Cancer Registries |
|
|
UKACR |
UK Association of Cancer Registeries |
|
|
UKCCCR |
UK Coordinating Committee for Cancer Research |
|
|
UKCCCR |
United Kingdom Coordinating Committee for Cancer Research |
|
|
UKCCRG |
United Kingdom Children's Cancer Research Group (Oxford) |
|
|
UKCCRG |
UK Children's Cancer Research Group |
|
|
UKCCSG |
United Kingdom Children's Cancer Study Group |
|
|
UKCCSG |
UK Children's Cancer Study Group |
|
|
ULN |
value/upper limits of normal |
|
|
ULR |
Universal Leukocyte Reduction |
|
|
umb |
navel |
|
|
UMCCC |
University of Michigan Comprehensive Cancer Center |
|
|
UNDIFF |
Undifferentiated |
|
|
UNI |
Universal Nobel Institute |
|
|
UOQ |
Upper Outer Quadrant |
|
|
Ur |
Urine |
|
|
URI |
Upper Respiratory Infection |
|
|
URO |
University Radiation Oncology Associates |
|
|
UROL |
Urology |
|
|
URPI |
Uro-Radiology Prostate Institute |
|
|
URTI |
Upper Respiratory Tract Infection |
|
|
US |
UltaSound |
|
|
USDHHS |
United States Department of Health and Human Services |
|
|
UTH |
University Teaching Hospital |
|
|
UTI |
Urinary Tract Infection |
|
|
UVR |
Ultra Violet Radiation |
|
|
UVR |
Ultraviolet Radiation |
|
|
Vag |
Vaginal |
|
|
VAG HYST |
Vaginal hysterectomy |
|
|
VAH |
Virginia A. Hodgkinson Research Prize |
|
|
VAIN |
Vaginal Intraepithelial Neoplasia |
|
|
VAS |
Vaccine Associated Sarcoma |
|
|
vasc |
Vascular |
|
|
Vcr |
Vincristine Sulphate |
|
|
VCR |
Vincristine |
|
|
VCS |
Veterinary Cancer Society |
|
|
VD |
Venereal Disease |
|
|
VEF |
Ventricular Ejection Fraction |
|
|
VFCR |
Victorian Family Cancer Register |
|
|
VFL |
Vinflunine |
|
|
VICC |
Vanderbilt-Ingram Cancer Center |
|
|
VIN |
Vulvar Intraepithelial Neoplasia |
|
|
VM-26 |
Vumon 26 (Teniposide) |
|
|
VMA |
Vanillyl Mandelic Acid |
|
|
VML |
Very Malignant Leanings |
|
|
VNB |
Vinorelbine |
|
|
VP-16 |
Vepesid 16 (Etoposide) |
|
|
VS |
vital signs |
|
|
W/ |
With |
|
|
W/F |
White female |
|
|
W/M |
White Male |
|
|
W/O |
Without |
|
|
W/U |
Workup |
|
|
WAAC |
Wargamers All Against Cancer |
|
|
WACKY |
War Against Cancer in Kids and Young |
|
|
WACN |
West Anglia Cancer Network |
|
|
WALC |
Women Against Lung Cancer |
|
|
WBC |
White blood cells |
|
|
WBCD |
Wisconsin Breast Cancer Database |
|
|
WBCP |
Wisconsin Breast Cancer Prognosis |
|
|
WBCU |
West Bank Cancer Unit |
|
|
WBRT |
Whole Brain Radiation Therapy |
|
|
WCC |
White Cell Count |
|
|
wcd |
World Cancer Day |
|
|
WCLS |
World Cancer Leaders' Summit |
|
|
WCN |
Women's Cancer Network |
|
|
WCRC |
Women's Cancer Resource Center |
|
|
WCRF |
World Cancer Research Fund |
|
|
wcrs |
Wisconsin Cancer Reporting System |
|
|
WCSP |
Wyoming Cancer Surveillance Program |
|
|
WCTR |
Wyoming Central Tumor Registry |
|
|
wd |
Well-Differentiated |
|
|
WDC |
Workforce Development Confederation |
|
|
WDLL |
Well-Differentiated Lymphocytic Lymphoma |
|
|
WDLS |
Well Differentiated LipoSarcoma |
|
|
WE |
Well differentiated |
|
|
WECAN |
Women's Empowerment Cancer Advocacy Network |
|
|
WHO |
World Health Organization |
|
|
WICR |
Women in Cancer Research |
|
|
WIFC |
Widely Invasive Follicular Carcinoma |
|
|
WJSG |
West Japan Study Group for Lung Cancer Surgery |
|
|
WJSO |
World Journal of Surgical Oncology |
|
|
Wm |
Waldenstrom's Macroglobulinemia |
|
|
WM |
Waldenstrom's macroglobulinaemia |
|
|
WOCA |
Wessex Oesophageal Cancer Audit |
|
|
WOKC |
Wipe Out Kids' Cancer |
|
|
WRCC |
Windsor Regional Cancer Centre |
|
|
WROA |
Western Radiation Oncology Associates |
|
|
WSBH |
World Society for Breast Health |
|
|
WSCR |
Washington State Cancer Registry |
|
|
WT |
Weight |
|
|
WT1 |
Wilms Tumor 1 protein |
|
|
WT2 |
Wilms Tumor 2 Protein |
|
|
WTCI |
Women's Therapy Centre Institute |
|
|
WTHD |
Wish to Hasten Death |
|
|
WTMG |
Western Tumor Medical Group |
|
|
WTZE |
WestDeutches TumorZentrum Essen |
|
|
Wum |
Wismut Uranium Miners |
|
|
WW |
watchful waiting |
|
|
WWBI |
Women's Well- Being Initiative |
|
|
WWCH |
Walla Walla Community Hospice |
|